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Abstract
Intrauterine growth restriction (IUGR) affects 10-15% of births and is associated with
placental insufficiency (PI), resulting in fetal oxidative stress (OS). This OS is a factor in the
predisposition to postnatal noncommunicable disease (NCD) of which muscle mitochondrial
dysfunctional is a key aspect. Pyrroloquinoline quinone (PQQ), an antioxidant-like
compound, is capable of OS reduction and promotes mitochondrial function, though limited
research has focused on its effects in in utero skeletal muscle. This study sought to
investigate the impact of in vitro H2O2, a model of OS, and an in vivo model of OS associated
IUGR, with PQQ administration, on fetal myogenesis and muscle mitochondrial function.
H2O2, IUGR, and unexpectedly PQQ, reduced expression of myogenic and mitochondrial
genes. Therefore, PQQ does not appear to attenuate OS-induced myogenic and mitochondrial
dysfunction and instead negatively altered associated genes. These changes have unknown
long-term consequences for altered muscle metabolism and its contribution to NCD.

Summary for Lay Audience
Babies grow quickly in the womb before birth, and when oxygen and nutrients are not
properly received, these babies have been shown to have an increased risk of later life
metabolic disease, such as diabetes or heart disease. This risk is specifically associated with
those who experience the hypoxia-associated pregnancy complication “placental
insufficiency” and endure intrauterine growth restriction (IUGR). A key reason for
development of these diseases after IUGR is the characteristic reduction in skeletal muscle
mass, as the organ plays an important role in whole body metabolism. The reduction is the
result of diminished blood delivery, as flow is shunted to more important organs to promote
survival after birth. It is predicted that early muscle mitochondrial dysfunction is the
underlying pathology that leads to development of metabolic deficits and oxidative stress due
to the hypoxic growth environment may be responsible for the organelle’s deterioration. This
study aimed to investigate the muscle mitochondrial impairments associated with exposure to
oxidative stress. Furthermore, it set out to determine if the antioxidant-like compound,
pyrroloquinoline quinone (PQQ), could prevent oxidative stress from damaging mitochondria
and instead promote function. A muscle cell culture model was utilized to isolate the effects
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of oxidative stress and PQQ on skeletal muscle development and mitochondrial function. A
second study utilized an IUGR fetal guinea pig model to determine the effects of IUGR and
PQQ on skeletal muscle development, including but not limited to, muscle mitochondrial
effects. Cells exposed to oxidative stress had reduced expression of genes associated with
muscle development and mitochondrial function, however, the addition of PQQ did not
lessen this decrease. Instead, PQQ itself decreased expression of the same genes. Similarly,
IUGR animals had reduced gene expression of muscle development, mitochondrial, and
metabolism markers, none of which showed increase after PQQ exposure but instead were
negatively affected by exposure to the compound. Previous research has shown PQQ to have
a positive effect on mitochondrial function in the liver, though this finding was not replicated
within the skeletal muscle. Therefore, this study highlights the compound’s opposing effects
in different organ systems and underlines the need for further research.

Keywords
Skeletal Muscle, Mitochondria, Pyrroloquinoline Quinone, Intrauterine Growth Restriction,
Oxidative Stress, Hydrogen Peroxide, C2C12
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Introduction

1.1 Fetal Reprogramming During Placental Insufficiency
and IUGR
Fetal reprogramming is defined as the physiological, structural, and metabolic changes
that occur in utero after exposure to certain adverse stimuli (Kwon & Kim, 2017).
Though the possible mechanisms of action behind such reprogramming remain unclear, it
is evident the changes that occur remain stable after birth and influence the life-long
health trajectories of the offspring (C. N. Hales et al., 1991; Marciniak et al., 2017).
Central to these mechanisms is the fact that during development, the fetus is especially
vulnerable to changes in placental function, including modifications to the relative rate of
oxygen delivery through the organ (Longtine & Nelson, 2011).
First trimester embryogenesis is characterized by a low-oxygen environment. Maternal
spiral arteries of the uterine tissue are blocked by a subpopulation of fetal endovascular
trophoblasts, limiting oxygen delivery to the placenta and creating a hypoxic in utero
growth environment (Weiss, Sundl, Glasner, Huppertz, & Moser, 2016) . This continues
until the 11-14 week of pregnancy, at which time maternal blood begins to flow through
the spiral arteries due to the invasion of cytotrophoblasts into the space around and inside
the spiral arteries to expand the vessels and supply the placenta with an increased blood
volume to support the growing demands of the fetus (Pijnenborg, Vercruysse, &
Hanssens, 2006; Whitley & Cartwright, 2009). Failure of the spiral arteries to remodel in
the second trimester as outlined results in an ischemic placenta (Roth et al., 2017;
Trudinger & Giles, 1996) otherwise referred to as “placental insufficiency” (PI)
(Chaddha, Viero, Huppertz, & Kingdom, 2004). PI is an idiopathic pregnancy
complication in which the placenta fails to obtain adequate maternal blood , restricting
fetal access to oxygen and nutrients. This often leads to a hypoxic growth environment
and reduction in nutrient delivery, and subsequent development of fetal growth restriction
(Hutter, Kingdom, & Jaeggi, 2010; Malhotra et al., 2019). Hence, PI is a known etiology
of intrauterine growth restriction (IUGR) (Burton & Jauniaux, 2018), or PI-IUGR for
short.
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IUGR is defined as growth below the 10th percentile (Faraci et al., 2011; Peleg, Kennedy,
& Hunter, 1998) and occurs within 10-15% of births worldwide (Suhag & Berghella,
2013). Compared to small-for-gestational age (SGA) infants, IUGR is pathological, in
that there is an increase in incidence for both perinatal morbidity and mortality (Garite,
Clark, & Thorp, 2004). Of the IUGR cases that develop due to PI, the majority are
categorized as “asymmetrical” growth restriction, which make up 70-80% of all IUGR
cases overall (Sharma, Shastri, & Sharma, 2016). The remaining percentage of cases are
defined as symmetrical, typically the result of early pregnancy insults that result in
proportional growth restriction due to sustained insult throughout gestation (Peleg et al.,
1998; Sharma et al., 2016).
Compared to symmetrical IUGR, asymmetrical growth restriction occurs as a result of
preferential distribution of blood flow during PI to organs vital for survival in
approaching postnatal life, including the brain and heart, at the expense of other organs
(Cohen, Baerts, & van Bel, 2015; Veille, Hanson, Sivakoff, Hoen, & Ben-Ami, 1993)
IUGR infants are observed as having proper measuring head circumferences and femur
length, compared to decreased abdominal circumference (Sharma et al., 2016). Organs
such as the skeletal muscle have inhibited growth, as a result of developing under
hypoxic conditions due to diminished blood flow (Rueda-Clausen et al., 2011). It is now
evident this hypoxia contributes to a predisposition in IUGR offspring to developing
noncommunicable diseases, such as cardiovascular disease (CVD) and type 2 diabetes
mellitus (T2DM) in adulthood (Rueda-Clausen et al., 2011), in part due to fetal
programming that occurs within the skeletal muscle (D T Yates et al., 2012). This
correlation was first observed by David Barker, and later coined the “developmental
origins of health and disease (DOHaD) hypothesis (Barker, 1998; C. N. Hales et al.,
1991).
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1.2 IUGR and DOHaD
In 1977, Dr. Forsdahl first documented an epidemiological correlation between early-life
poverty and adulthood coronary heart disease. He speculated that a form of permanent
damage occurred due to nutritional deficits that resulted in the predisposition to CVD
observed (Forsdahl, 1977). Further building of Forsdahl’s original findings, David Barker
specifically postulated fetal adaption to a low nutrient supply programs changes to fetal
organs that predispose the individual to adult-onset NCD (Barker, 1998). It was made
evident by the “Barker’s hypothesis” that sufficient maternal blood flow to the
developing fetus was not only important for immediate fetal development but had longterm effects implications as well. Similar to low nutritional supply insult originally
documented by Barker (1998), insufficient oxygen delivery to and across the placenta
(I.e., hypoxia) has also been shown to elicit the same harm, like that seen in PI-IUGR
specifically (Chu et al., 2019; Su, Lv, Xie, Wang, & Lin, 2013).
The role the in-utero environment plays in life-long metabolic health developmental
trajectories is now increasingly relevant, as the prevalence of NCDs throughout the world
continues to rise (Moore, Chaudhary, & Akinyemiju, 2017; Ranasinghe,
Mathangasinghe, Jayawardena, Hills, & Misra, 2017). It appears restricted fetal growth is
associated with increased incidence of insulin resistance (IR) development, the precursor
for several metabolic diseases (C. Nicholas Hales & Barker, 2001). Skeletal muscle is an
essential endocrine organ and the reduction in muscle mass seen in IUGR is specifically
associated with said decreased insulin sensitivity (Phillips, Barker, Hales, Hirst, &
Osmond, 1994; Xing et al., 2019). In utero, total muscle mass of an individual is
determined by relative rates of myogenesis and there is a rate reduction in this process
seen during IUGR (Chang et al., 2020). Importantly, this mass reduction appears to
persist into adulthood (Năstase, Cretoiu, & Stoicescu, 2018). An understanding of the
specific cellular physiological programming that result in and from reduced myogenesis
during IUGR would therefore aid in understanding the role skeletal muscle plays in laterlife risk of NCDs in IUGR offspring. More recently, IUGR diagnostic criteria has widen
to include those infants who are born above the 10th percentile, 2,500g threshold but may
have still been unable to reach their regular developmental milestones at a molecular
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level independent of birth weight (Sharma et al., 2016), highlighting that an adverse in
utero environment that does not result in a decreased birth weight may still program
metabolic disease risk at the molecular level (Morris, Say, Robson, Kleijnen, & Khan,
2012).

1.3 Hypoxia and Associated Oxidative Stress
The exact mechanisms of programming that occur during IUGR are not well defined,
however it has been postulated that the oxidative stress (OS) that develops as a
consequence of hypoxia is responsible (Aljunaidy, Morton, Cooke, & Davidge, 2017;
Thompson & Al-Hasan, 2012). OS is defined as the imbalance between reactive oxygen
species (ROS) and endogenous antioxidant defense mechanisms, primarily superoxide
(SOD), catalase (CAT), and glutathione (GSH) (Birben, Sahiner, Sackesen, Erzurum, &
Kalayci, 2012). Collectively, SOD and CAT aim to eliminate two potent ROS,
superoxide (O-) and hydrogen peroxide (H2O2), respectively (Birben et al., 2012).
Similarly, GSH aids in the elimination of H2O2 alongside CAT (Antunes, Han, &
Cadenas, 2002). Three major cellular systems appear to produce the majority of ROS
including mitochondrial metabolism, NADPH oxidase (NOX), and xanthine oxidase
(XO). Under physiological conditions, complex I (NADH:ubiquinone oxidoreductase)
and complex III (ubiquinol:cytochrome c oxidoreductase) of the mitochondrial electron
transport chain (ETC) produce endogenous oxygen free radicals due to electron leakage
during energy production. Further modifications to these free radicals result in superoxide
and H2O2 formation. Likewise, NOX produces superoxide and H2O2 as a by-product of its
transfer of electrons across the cell membrane. Lastly, XO is a potent source of
superoxide; production accompanies one of xanthine oxidase primary functions,
oxidation of hypoxanthine to xanthine. In short, ROS production is inevitable under
normal physiological conditions and its production alone does not definitively lead OS. It
is the degree to which ROS outcompetes antioxidant activity that is fundamental to
understanding OS establishment during pregnancy.
Physiological concentrations of ROS serve a critical role in pregnancy, as modulated
levels are essential for effective cellular signalling during placentation and beyond
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(Soares, Iqbal, & Kozai, 2017). For example, the initial hypoxic growth environment is
intended to protect the placenta and early embryo against damage due to oxidative stress
(OS), as neither have developed sufficient antioxidant abilities to reduce ROS
concentrations. In other words, a premature influx of oxygen through the placenta, and
subsequent increase in cellular metabolism in early pregnancy results in elevated
production of ROS that the ill-developed SOD and CAT within the placenta and embryo
cannot combat, ultimately resulting in OS (Jauniaux et al., 2000; Takehara, Yoshioka, &
Sasaki, 1990). Hence, the hypoxic growth environment throughout the first ten weeks of
pregnancy is critical to reach the stage of fetal development.
As fetal development progresses, the relatively hypoxic environment is meant to
diminish. However, under conditions in which the placenta fails to thrive including PIIUGR, adverse, chronic placental and fetal hypoxia develops. Unlike the beneficial
effects seen during embryonic development, hypoxia due to PI is associated with OS
production within the placenta and fetus (Schoots, Gordijn, Scherjon, van Goor, &
Hillebrands, 2018). As previously described, blood flow is redistributed to vital organs
and shunted away from the skeletal muscle as a result of the hypoxic environment of PIIUGR. This process is conducive of OS development within the skeletal muscle itself as a
result of the direct decrease in partial pressure of oxygen within the organ (Clanton,
2007). The effects of OS on myogenesis are well established and it is a known
contributor to the decrease in skeletal muscle evident during IUGR. In addition to the
negative effects of decreased nutritional intake of the skeletal muscle mass during IUGR
(Bhasin et al., 2009; Năstase et al., 2018), OS appears to reprogram regulator factors of
myogenesis to inhibit fiber development directly (Chang et al., 2020).

1.4 Myogenesis
To understand how OS affects myogenesis, physiological myogenic processes must first
be described. Much of the muscle growth precedes birth, highlighting the importance of
the fetal environment for adequate skeletal muscle development and growth (Yan, Zhu,
Dodson, & Du, 2013). Myogenesis commences during the embryonic stages of
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development, termed primary myogenesis. Early muscle cells are collected within the
primitive dermomyotome and have marked expression of pair boxed transcription factors
PAX3 and PAX7 (Goulding, Chalepakis, Deutsch, Erselius, & Gruss, 1991; Jostes,
Walther, & Gruss, 1990). Both transcription factors regulate specification of cells to
myogenic commitment, while also activating downstream myogenic regulatory genes
such as myoblast determination protein 1 (MYOD1) and myogenic factor 5 (MYF5).
After disintegration of the dermomyotome, PAX3+/PAX7+ committed cells align within
the new myotome in which future limbs are derived and evolve to express terminal
skeletal muscle specification markers, including Myod1 and Myf5 (Rudnicki et al.,
1993).
The myogenic regulatory factors are highly conserved genes consistently expressed at
one time during skeletal muscle development and include MYOD1, MYF5, in addition to
Myogenin (MYOG), and MRF4 (Weintraub et al., 1991). MYF5 is the initial factor to be
expressed, but then decreases in line with myotube fusion (Ott, Bober, Lyons, Arnold, &
Buckingham, 1991; Zanou & Gailly, 2013). Confirmation of the importance of MYF5 to
primary myogenesis came when mice devoid of MYF5 displayed delayed skeletal muscle
development. Of note, induced gene expression of Myod1 then rescued muscle
development, highlighting the importance but also redundancy of MYF5 in the presence
of MYOD1 (Braun, Rudnicki, Arnold, & Jaenisch, 1992). The redundancy of both factors
was further highlighted, when skeletal muscle developed adequately in MYOD1-null
mice, as a result of compensatory Myf5 gene expression (Rudnicki, Braun, Hinuma, &
Jaenisch, 1992), while knockout of both resulted in failure of skeletal muscle to grow
(Rudnicki et al., 1993; M. Yamamoto et al., 2018), exemplifying that at least one of the
two factors must stay conserved. Downstream factor MYOG is skeletal muscle specific,
with early expression in primary myogenesis and continued activation until mature
muscle fibers develop during secondary fetal myogenesis, which fail to form in Myogknockout experiments, accentuating the factor’s necessity (Venuti, Morris, Vivian, Olson,
& Klein, 1995). MRF4 expression similarly spans embryonic and fetal myogenesis,
serving as a myogenesis determination gene like Myf5 and Myod1, and continuing to be
expressed throughout fetal myofiber development. Though once hypothesized that
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differentiation was solely controlled my Myf5 and Myod, recent research has shown that
Mrf4 expression is additionally necessary for adequate myogenesis. Knockout of either
Myf5 or Myod1 in combination with Mrf4 expression, supports sufficient muscle
development for postnatal survival and it is now believed MRF4 works upstream of
MYOD1, similar to MYF5 (Kassar-Duchossoy et al., 2004). Of note is the importance of
MRF4 in adult skeletal muscle, serving as the predominant expressed factor
(Hinterberger, Sassoon, Rhodes, & Konieczny, 1991) (Figure 1.4-1).

Figure 1.4.1-1 Regulation of embryonic and fetal myogenesis.
Transcription factor/gene expression is shown by a solid line and declining expression is
represented by dotted lines. Figure modified from the “The Basis of Muscle
Regeneration” article (Musarò, 2014).
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The type of fiber that develops from primary and secondary myotubes is determined by
the myosin protein composition within each. The fibers are then further classified in
accordance with their relevant physiological capabilities. Simply, fibers are classified as
type I (slow) or type II (fast), based on at which speed in which sarcomeres shorten
(Bárány, 1967; Huxley & Niedergerke, 1954; Talbot & Maves, 2016). Myosin heavy
chain isoform genes corresponding to type I fibers, including Myh7, are expressed
beginning in embryonic myogenesis. Comparatively, expression of type II fiber myosin
heavy chain isoform genes Myh4, Myh2, and Myh1 does not occur until the fetal stages
of muscle development (Glaser & Suzuki, 2018). Fiber type is additionally influenced by
myogenic regulatory factor, MYOD1, in that Myod gene expression is important for type
II fiber specification and maintenance (Hughes, Koishi, Rudnicki, & Maggs, 1997;
Talbot & Maves, 2016).
Lastly, the regenerative capacity of skeletal muscle, otherwise described as adulthood
myogenesis, is attributed to a select population of reserved PAX3+/PAX7+ satellite cells
maintained throughout primary and secondary myogenesis. PAX3 and PAX7 are
redundant in that PAX7 can replace PAX3 in most functions, and PAX7 appears to be
necessary for postnatal myogenesis specifically (Olguin & Olwin, 2004; Relaix,
Rocancourt, Mansouri, & Buckingham, 2005; Seale et al., 2000). PAX7 expression in
turn inhibits MYOD expression to arrest cells in a proliferative state by inhibiting further
myogenesis induction (Olguin & Olwin, 2004). Upon skeletal muscle injury, mentioned
PAX7+/MYOD- cells regain myogenic properties and fuse to injured myofibers to allow
regeneration (Moss & Leblond, 1971; Snow, 1977; Von Maltzahn, Jones, Parks, &
Rudnicki, 2013). Early damage to described satellite cell pool could therefore be
postulated to inhibit future regenerative capacity.

1.4.1

Hypoxia/OS and Myogenesis

As stated previously, myogenesis is altered under hypoxic growth conditions.
Phenotypically, muscle mass, and subsequent myofiber area and diameter is reduced
under conditions of low oxygen (Howald & Hoppeler, 2003; Scholz, Thomas, Sass, &
Podzuweit, 2003). Expression of MYOD1 and subsequently MYOG, is significantly
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decreased, suggesting slowed myogenesis, providing a molecular explanation for
decreased skeletal muscle size under pathological hypoxic conditions (Yun, Lin, &
Giaccia, 2005). It is important to note that it is under extended hypoxic conditions that
such adverse effects are observed, in part due to chronic activation of HIF-1𝛼. Acute
exposure induces HIF-1𝛼, though this short-term activation is said to be beneficial, in
that studies have documented stimulation of myogenesis under these conditions (Cirillo
et al., 2017). Inversely, recurrent activation of HIF-1𝛼 inhibits MYOD1 expression,
therefore disrupting myogenesis (Di Carlo et al., 2004). IUGR is similarly associated
with decreased MYOD1 and MYOG (Chang et al., 2020), and a reduction in the
proliferative capacity of myoblasts (Dustin T Yates et al., 2014). Overexpression of HIF1𝛼 to mimic a hypoxic growth environment is also associated with IUGR mice offspring
with decreased skeletal muscle mass (Tal et al., 2010). These results together highlight
that reduction of skeletal muscle mass in IUGR occurs in association hypoxia and could
be explained by molecular dysregulation of myogenesis in utero, possibly due to OS
during P-IUGR. Though PI- IUGR occurs later in pregnancy, the secondary (fetal)
myogenesis occurring during this time has a larger impact on muscle size than early
embryonic myogenesis. Fetal myogenesis is the process in which secondary muscle fibers
form through the fusion of myoblasts to primary myotubes, and these secondary fibers
account for the majority of skeletal muscle mass (Weimer & DiMario, 2016). This could
explain why PI-IUGR and resulting OS has such a marked effect on the organ’s size
although the condition develops relatively late in gestation (Chang et al., 2020).

1.4.2

IUGR’s Effects on Muscle Fiber Type and Mitochondrial
Metabolism

Skeletal muscle fibers vary in energy production and oxidative capacity, dependant in
part by their relative mitochondrial content (Crupi et al., 2018). Slow fibers are
characterized by their high myoglobin and capillary content, associated with relatively
increased oxidative capacity, and slow contractions allow for increased mitochondrial
oxidative phosphorylation and subsequent ATP production (Glaser & Suzuki, 2018). In
comparison, type II fibers are associated with anaerobic metabolism, in that they possess
fewer mitochondria and rely on glycolysis for contractile ATP energy (Glaser & Suzuki,
2018). Type II fibers can be further defined as being type IIa, IIb, or IIx. Type IIx and IIb
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fibers are considered glycolytic fibers, in comparison to Type IIa, commonly referred to
as the “intermediate fiber”, with both glycolytic and oxidative capacity. It is important to
note that Type IIb muscle fibers are only present in small mammals, and not humans
(Tellis, Rosen, Thekdi, & Sciote, 2004).
Interestingly, this specification is considered plastic and fiber type “switching” is a welldocumented mechanism that can occur during development and into adulthood (Buller,
Eccles, & Eccles, 1960). Fiber type switching in utero results from changes in the
metabolic environment (Bourdeau Julien, Sephton, & Dutchak, 2018), while in adulthood
exercise commonly results in fiber type switches resulting in increased accumulation of
fibers with relatively high oxidative capacity, like type I (S. H. Lee, Kim, Park, & Kim,
2018).
Muscle fiber type switching during IUGR has been documented, though the multiple
studies conducted are contradicting to one another. Early studies reported an increased
proportion of type I fibers in lower limb muscle of IUGR piglets (Bauer, Gedrange,
Bauer, & Walter, 2006; Wank et al., 2000). Similarly, maternal diet restriction alone has
been shown to promote a decrease in type II fiber concentration, accompanied by an
increase in type I fibers within hind limb muscle of sheep (Fahey, Brameld, Parr, &
Buttery, 2005). Conversely, more recent experimentation showed IUGR resulted in an
increased proportion of type II fibers in sheep hind limb muscle and subsequent decrease
in type I (Dustin T Yates et al., 2016). Of importance is long-term studies showing
documented increases of type I fibers in IUGR sheep after 2 weeks of age, replaced by
higher proportion of type II muscle fibers at 25 weeks (Daniel, Brameld, Craigon,
Scollan, & Buttery, 2007). It could be postulated that early data showing type I fiber
density increases is only a short-term rescuing effect (Brown, 2014). Overall, there is still
speculation of the type of muscle fiber production that is favored in IUGR fetuses and
offspring. In considering all the above studies, it could be theorized that in utero
reprogramming during IUGR insult initially favors the mitochondrial-dense type I fibers
to compensate for decreases in mitochondrial function, but then type I fiber
concentrations are eventually decreased to reduce mitochondrial metabolism and
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subsequent ROS production, in hopes of limiting the subsequent oxidative damage that
occurs in association with IUGR.
The life-long effects of such switches are relatively unknown. Healthy adult humans have
approximately the same number of satellite cells within type I and type II muscle fibers
within the body (Kadi, Charifi, & Henriksson, 2006). Though, type II fibers do diminish
faster with age (compared to type I), and therefore have diminished regenerative capacity
later in life (Verdijk et al., 2014). When exposed to in utero stress, like IUGR, satellite
cell populations are diminished (Stange, Miersch, Sponder, & Röntgen, 2020), providing
the basis for the hypothesis that IUGR could inhibit previously described muscle
regeneration in adulthood.

1.4.3

Relationship between mitochondrial function and
myogenesis

Of note, is the role the mitochondria play in myogenesis, and vice versa. Differentiation
of myoblasts is associated with an increase in oxidative phosphorylation and therefore,
mitochondrial biogenesis (Wagatsuma & Sakuma, 2013). Comparably, MYOD1 was
found to bind with PPAR-𝛾 coactivator-1-𝛽 (PGC-1𝛽), alongside other metabolically
related genes and positively modulate oxidative metabolism (Shintaku et al., 2016).
Similarly, muscle metabolism is highly regulated by the peroxisome proliferatoractivated receptor (PPAR) family of transcription factors, in part by their regulation of
fiber type distinction, in concert with PGC-1𝛼 (Schuler et al., 2006). PGC-1𝛼- induced
skeletal muscle remodelling is associated with conversion of glycolytic fibers types to
those that favour oxidative metabolism (Mortensen, Frandsen, Schjerling, Nishimura, &
Grunnet, 2006). Hence, adequate myogenesis is responsible for proportion of
mitochondrial metabolism and subsequent function, while mitochondrial function is also
important for the growth of skeletal muscle. Interestingly, skeletal muscle mitochondrial
dysfunction specifically is evident in IUGR offspring, in both fetal and postnatal studies
(K. Cheng et al., 2020; Pendleton et al., 2020), and it is postulated that both findings are
the result of OS (J. A. Kim, Wei, & Sowers, 2008; Rodríguez-Rodríguez et al., 2018). It
is important to note that mitochondrial dysfunction has been investigated as a key
contributor to the susceptibility of metabolic disease observed within IUGR offspring
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(Liu et al., 2012; Pendleton et al., 2020). Therefore, it appears OS programs both
inhibitions and myogenesis and downstream mitochondrial function directly, that likely
contribute to NCD risk.

1.4.4

Muscle Mitochondrial Dysfunction

Increased ROS production in part due to mitochondrial electron leakage during OS can
damage the organelle’s proteins, enzymes, and lipids directly resulting in increased
electron leakage and further free radical production. Hence, mitochondrial dysfunction
ultimately facilitates more ROS generation and sustains OS through a positive feedback
loop of damage. Additionally, continued OS exposure to the organelle results in
mitochondrial DNA damage, leading to mutations in the mitochondrial genome that
compound existing dysfunction as a result of previously mentioned OS damage
(Hollensworth et al., 2000). Of note is the specific decrease in expression of Pgc-1𝛼 in
IUGR offspring, that both contributes to OS and to further mitochondrial dysfunction
(Pendleton et al., 2020; Zeng, Gu, Liu, & Huang, 2013).
Though commonly referred to in the context of mitochondrial biogenesis, the increase of
mitochondrial mass, protein peroxisome proliferator-activated receptor-gamma
coactivator (PGC)-1𝛼 is also a regulator of the mitochondrial antioxidant defense system
that works to mitigate OS and prevent the described mitochondrial damage. In
environments of elevated hypoxia and OS, induction of PGC-1𝛼 is evident (Zhu et al.,
2010) and overexpression of the coactivator is associated with decreased ROS
accumulation and relative reduction of mitochondrial apoptosis (Valle, ÁlvarezBarrientos, Arza, Lamas, & Monsalve, 2005). Additionally, mitochondrial SOD
(MnSOD/SOD2) levels are increased upon similar overexpression (St-Pierre et al., 2003).
Overall, PGC-1𝛼’s protective effects within the mitochondria appear to mediated in-part
due to a PGC-1𝛼 – MnSOD dependent pathway through an interaction with the
mitochondrial deacetylase, Sirtuin 3 (SIRT3) (Kong et al., 2010; Wang et al., 2015).
SIRT3 is a known regulator of mitochondrial function and energy homeostasis (Ahn et
al., 2008), as a downstream target of PGC-1𝛼 (Kong et al., 2010). It is through activation
of SIRT3 that increased PGC-1𝛼 expression elicits increased MnSOD levels. SIRT3 can
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additionally feedback to PGC-1𝛼 itself to promote mitochondrial biogenesis and overall
function when expressed to aid in prevention of the organelle’s demise due to OS
(Jornayvaz & Shulman, 2010; J. Zheng et al., 2018). Under physiological stress, like OS,
PGC-1𝛼 interacts with transcriptional factors involved in mitochondrial biogenesis,
including nuclear receptor factors (NRF) 1 and 2, and transcription factor A,
mitochondrial (TFAM). Increased expression of PGC-1𝛼 induces the transcription of
NRF-1 and 2, which in turn increase expression of TFAM (Taherzadeh-Fard et al., 2011).
TFAM is essential for oxidative phosphorylation, encoding 13 components of the ETC
(Bonawitz, Clayton, & Shadel, 2006; Falkenberg, Larsson, & Gustafsson, 2007), in
addition to driving mitochondrial biogenesis through regulation of gene transcription and
replication of mitochondrial DNA (Ngo, Lovely, Phillips, & Chan, 2014). In short, the
decrease in PGC-1𝛼 evident during IUGR is likely a large contributing factor to the
mitochondrial dysfunction evident in IUGR due to decreases in mitochondrial biogenesis
but may also contribute to further mitochondrial damage by OS because of reduced
expression of downstream MnSOD.

1.5 Antioxidant Therapy
As a result of the host of diseases that have been attributed in some part to OS, the
potential for exogenous antioxidant therapies to prevent and treat said disorders is
notable. Exogenous antioxidant consumption within our regular diets complements
existing endogenous antioxidant defense mechanisms. These groups of dietary
antioxidants include ascorbic acid (vitamin C) and tocopherol (vitamin E), carotenoids,
and polyphenols, and can be classified as “bioactive”. A bioactive compound is one in
which, after consumption, can elicit an effect on the body. This effect can be positive or
negative, and effective dosing of said compounds is critical in preventing negative
consequences.

1.5.1

Early Studies of Antioxidant Treatment Options

The emergence of OS as a contributing factor to preeclampsia in early research prompted
studies utilizing vitamin C and E supplementation to attempt to reduce occurrence of the
disorder. Similarly, early studies on pregnancy loss found an association between
miscarriage as well as IUGR and decreased maternal vitamin C and E serum
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concentrations. Vitamin C acts a scavenger for ROS, eliminating them to minimize OS.
Vitamin E is similar in function, as it scavenges lipid peroxyl radicals of lipid
peroxidation to prevent ROS-mediated cellular damage and more recently has been
documented to be an inhibitor of NADPH oxidase activity, a previously mentioned
contributor to OS. Initial studies found vitamin C and E supplementation decreased
expression of markers of preeclampsia, specifically the ratio of PAI-1 to PAI-2, which is
a common clinical measure for the disorder. Incidence of preeclampsia was also
significantly reduced in those who were diagnosed with predisposition to preeclampsia
after taking both vitamins. These findings encouraged further research, with several
others trying to replicate the positive results, including in models of IUGR.
Unfortunately, reproducibility of the positive effects on preeclampsia occurrence was
low, and high doses of each vitamin were needed to elicit positive effects in pregnancy.
Concerningly, the high dosages experimented with in animals would pose health risks to
humans (D.-H. Lee, Folsom, Harnack, Halliwell, & Jacobs, 2004). Lastly, several studies
showed vitamin C and E supplementation during pregnancy increased the risk of
premature rupture of membranes (PROM) (Spinnato et al., 2008). In 2019, the World
Health Organization (WHO) concluded vitamin C and E is not recommended to improve
maternal and perinatal outcomes during pregnancy (WHO, n.d.).

1.5.2

Mitochondria-Targeted Therapies

Mitochondrial dysfunction is evident during several other adverse pregnancy conditions
linked to OS like PI-IUGR, in addition to the role it plays in metabolic disease (Bhatti,
Bhatti, & Reddy, 2017). As such, recent research into treatments for such disorders has
focused on those that target the organelle and promote functioning.
Resveratrol (RSV) is a bioactive polyphenol compound found in plants synthesized to
protect the organism against injury. It is found in a variety of food and drink products but
is most widely recognized for its existence in wine. It initially became popular as a
potential beneficial supplement when studies showed cardiovascular health benefits after
regular and moderate wine drinking as a result of RSV consumption. Several studies have
shown the compound to act as an antioxidant, though it is not a strong free radical
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scavenger itself. RSV primarily elicits its antioxidant effects by activating transcription
factors important for redox balance within the body, including the activation of
mitochondrial-bound antioxidant pathways through increased Sirt1 expression to
diminish ROS production by the organelle (Ungvari, Sonntag, De Cabo, Baur, & Csiszar,
2011). RSV additionally directly promotes proper mitochondrial biogenesis through this
same pathway (Ungvari et al., 2011). Compared to vitamins C and E, RSV’s effects on
pregnancy have not been thoroughly studied in humans It has however been shown to
cross the placenta in several animal studies and increase uterine blood flow, thereby
increasing oxygen delivery and indirectly decreasing hypoxia-induced ROS in the fetus.
In a rodent model of preeclampsia, antioxidant enzyme SOD was upregulated in placental
trophoblasts following maternal consumption of RSV, and oxidative stress, defined as
relative malondialdehyde (MDA) content, was reduced to a level that prevented apoptosis
of in the same placental cells during pregnancy (Zou et al., 2014). It is important to note
that RSV bioavailability appears to be low due to rapid metabolism within the body
(Sergides, Chirilă, Silvestro, Pitta, & Pittas, 2016). It is therefore likely that continued
supplementation throughout pregnancy would be needed to elicit an effect on the mother
and fetus during pregnancy (S. Zheng, Feng, Cheng, & Zheng, 2018) and overall, the
safety and efficacy of such treatment is not yet well understood, though preliminary data
shows RSV exposure throughout gestation may inhibit fetal pancreas development
(Roberts et al., 2014).
MitoQ is an antioxidant compound specifically designed to mimic the endogenous
mitochondrial antioxidant coenzyme Q10 (CoQ10) (Tauskela, 2007). CoQ10 serves as a
cofactor to the ETC to promote energy production and is a significant lipid antioxidant
that simply reduces production of ROS (Saini, 2011). MitoQ was designed to specifically
accumulate within the mitochondria and augment the action of existing CoQ10 (Gottwald
et al., 2018). Human studies of MitoQ’s effects in pregnancy are limited and the
manufacturer currently recommends it not be taken while pregnant. Early research
showed that in rodent models of placental insufficiency, MitoQ does protect against
placental hypoxia and subsequent OS by increasing placental maternal blood space
volume and surface area (Nuzzo et al., 2018). Unfortunately, MitoQ uptake within the
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developing fetus was low, and it was concluded the beneficial effects of MitoQ will
likely only be seen at the placental level (Nuzzo et al., 2018), inferring that
administration of MitoQ after onset of placental dysfunction would not help prevent
negative fetal changes that may have already occured. The compound's specific effects in
incidences of preeclampsia and IUGR are relatively unknown. Though, one recent study
using a mouse model of reduced placental perfusion concernedly found that early
pregnancy MitoQ supplementation exacerbated placental dysfunction by inhibiting
placenta development and that it can also increase the risk of preeclampsia development
(Yang et al., 2021). It has been concluded since that with early pregnancy administration
of antioxidants, and the role ROS play as signaling molecules that promote placental
development needs to be considered in future research (Yang et al., 2021).
Of particular interest is the novel bioactive antioxidant-like compound pyrroloquinoline
quinone (PQQ), found in commonly consumed food items, especially kiwi, parsley, and
soybeans (Kumazawa, Sato, Seno, Ishii, & Suzuki, 1995). It is also found in breast milk,
highlighting the plausible importance of the compound in early postnatal life (Mitchell,
Jones, Mercer, & Rucker, 1999). Like both MitoQ and RSV, it has positive effects on
mitochondrial function, including in vitro stimulation of biogenesis within the liver
through activation of PGC-1𝛼 (Chowanadisai et al., 2009). As previously described,
increased PGC-1𝛼 expression is associated with increased activity of mitochondrial
antioxidants (Kong et al., 2010; Wang et al., 2015), which is in part how PQQ
additionally reduces ROS production and OS. PQQ also directly acts as a ROS scavenger
itself (Misra et al., 2004). Overall, PQQ has been shown to be 100-1000 times more
effective than other antioxidants at reducing concentrations of ROS within the body (T.
E. Stites, Mitchell, & Rucker, 2000). Lastly, it is effective at microgram quantities
(Harris et al., 2013) unlike vitamin C and RSV, and therefore diminishing the risk that it
will elicit harmful effects in pregnancy like those seen with high-dose vitamin C and E
supplementation.
PQQ’s effects during pregnancy are not well studied; many of its known positive effects
were studied in a postnatal or adult environment. It has however known to increase
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placental surface area and weight (Jonscher, Stewart, Alfonso-Garcia, DeFelice, Wang,
Luo, Levi, Heerwagen, Janssen, De La Houssaye, et al., 2017), as well as significantly
increase the number of viable offspring and expression of antioxidant genes within the
placenta when given throughout pregnancy in sows (B. Zhang et al., 2019). Similarly,
Jonscher et al. (2017) additionally found prenatal PQQ treatment decreased indices of
liver OS, induced by maternal obesity and a high fat diet, in offspring of mice fed PQQ
throughout gestation. In regard to IUGR, PQQ shows promise in that it positively acts on
PGC-1𝛼 (Chowanadisai et al., 2010) which was previously stated to be downregulated in
IUGR (Zeng et al., 2013) and other adverse metabolic conditions (Riehle & Abel, 2012;
Son et al., 2020). Overall, direct studies of the effects of PQQ supplementation during PIIUGR are lacking, and its effects on skeletal muscle development in utero are unknown.

1.6 Thesis Rationale and Objectives
1.6.1

Rationale

The prevalence of noncommunicable diseases continues to increase throughout the world
(Moore et al., 2017; Ranasinghe et al., 2017). An adverse in utero environment during
development increases the risk of developing these disorders in adulthood (Dunlop,
Cedrone, Staples, & Regnault, 2015) including the relatively hypoxic environment
associated with PI-IUGR (Rueda-Clausen et al., 2011). As blood flow is diverted to the
brain and heart, which are more critical for long-term survival, diminished concentrations
of oxygen and nutrients reach the developing skeletal muscle and growth is impeded. The
reduction in growth is associated with changes to mitochondrial gene and protein
expression and subsequent alterations in mitochondrial function. This phenomenon
results in increased incidences of IR, a key precursor to NCD (J. A. Kim et al., 2008;
Simmons, Suponitsky-Kroyter, & Selak, 2005; H. Zhang, Li, Hou, Zhang, & Wang,
2016). Skeletal muscle is the principal organ responsible for glucose uptake, and
alterations to mitochondrial gene expression impede this process, contributing to the
generation of IR and subsequent NCD. In short, the adverse in utero environment is
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proposed to reprogram key muscle mitochondrial genes, contributing to the
predisposition to metabolic disease observed in IUGR offspring.
PI-IUGR is a form of placental failure that results in the development of fetal OS
(Guvendag Guven, Karcaaltincaba, Kandemir, Kiykac, & Mentese, 2013). As blood
oxygen concentrations decrease during IUGR progression, an increased concentration of
ROS is produced (Rashid, Bansal, & Simmons, 2018). This increase in ROS cannot be
subdued by endogenous antioxidant mechanisms, and hence forth, there is development
of OS. Mitochondrial dysfunction is often defined as a reduction in ETC complex
abilities and overall energy production. It is widely observed that OS and mitochondrial
function have an inverse relationship, in that increased OS can damage the organelle
(Hollensworth et al., 2000) and the mitochondria themselves can contribute to OS
production under adverse conditions (Taddei et al., 2012). Gene and associated protein
expression related to mitochondrial function such as those of the ETC have been reported
to be significantly decreased in in vivo and in vitro models of OS (Guitart-Mampel et al.,
2019; Pendleton et al., 2020). Of note, OS is associated with epigenetic modulating
effects (Campos et al., 2007), and it has been postulated that this the mechanism behind
decreased expression of key mitochondrial function genes observed in IUGR.
Given that OS is associated with several adverse pregnancy conditions in addition to PI–
IUGR, exogenous antioxidant therapies to treat these conditions has and continues to be
explored. Initial research examined the use of vitamin C and E as treatment options for
the OS-associated pregnancy conditions such as preeclampsia (Shennan & Duckworth,
2010). Data showed no benefit, and in some cases, more harm including increased
incidence of premature rupture of membranes (PROM), as a result of vitamin C and E
exposure together during pregnancy (Spinnato et al., 2008). Acknowledging the
importance of mitochondrial dysfunction in OS progression and furthermore the
association between disease states and mitochondrial dysfunction, recent research has
focused on compounds specifically targeting the organelle. Resveratrol, a bioactive
polyphenol, has been shown to increase mitochondrial function, including ETC complex
activity (Gueguen et al., 2015), but its low bioavailability suggests the need for continued
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maternal consumption through pregnancy to elicit effects, which may harm development
of the fetus (Roberts et al., 2014). MitoQ, a compound designed to mimic an endogenous
mitochondrial antioxidant, but early gestation supplementation was shown to inhibit
placental development (Yang et al., 2021).
A possibly more effective supplement is the compound pyrroloquinoline quinone (PQQ).
PQQ is a bioactive, antioxidant-like compound shown to promote mitochondrial
biogenesis alongside decreasing OS (Chowanadisai et al., 2010; Nunome, Miyazaki,
Nakano, Iguchi-Ariga, & Ariga, 2008). PQQ is active at only milligram quantities (T.
Stites et al., 2006) and participates in redox cycling to recycle its antioxidant abilities
(He, Nukada, Urakami, & Murphy, 2003). The ability for it to function at small
quantities in comparison to other conventional antioxidant suggests PQQ can act without
the adverse effects reported in other studies, like those observed with Vitamin C (D.-H.
Lee et al., 2004). For reference, humans consume an average of 0.1-1.0 mg per day in
their diet (Harris et al., 2013).
Harris et al. (2013) found that at consumption of 0.2 - 0.3 mg PQQ/kg/day for 2-3 days
resulted in a significant increase to antioxidant activity, and a reduction in indices of
inflammation within collected plasma. PQQ with the same scaled doses, accounting for
heightened metabolism in mice, found similar results, in that postnatal offspring were
protected from hepatic lipotoxicity and inflammation if exposed to PQQ in utero and in
early life (Jonscher, Stewart, Alfonso-Garcia, DeFelice, Wang, Luo, Levi, Heerwagen,
Janssen, de la Houssaye, et al., 2017). Overall, though the positive effects of PQQ are
evident in postnatal studies, its effects in a in utero setting are relatively unknown.
Additionally, limited studies have investigated the effects of PQQ on skeletal muscle
development.

1.6.2

Objectives and Hypotheses

The first objective was to determine the effects of short and long-term PQQ treatment on
muscle cell differentiation and markers of mitochondrial function in a cell culture model
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of fetal skeletal muscle development, when challenged with H2O2 mimicking an OS
environment. It was postulated that H2O2 would negatively alter skeletal myogenesis
pathways, and that PQQ treatments would mitigate OS and rescue myogenesis and
markers of mitochondrial function.
The second objective was to study the effects of maternal PQQ administration during
pregnancy on normal growth and IUGR fetal skeletal muscle myogenesis and markers of
mitochondrial function. It was postulated that IUGR would be associated with altered
myogenesis and markers of decreased mitochondrial function while PQQ consumption
during pregnancy would reduce measures of OS, in conjunction with the promotion of
myogenesis and muscle mitochondrial function in both normal and IUGR fetuses.
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2

Methods and Materials

2.1 C2C12 Cells: H2O2 and PQQ Supplementation
The C2C12 immortalized Mus muculus (i.e. mouse) myoblast cell line was utilized for in
vitro experimentation. The cell line is a subclone of myoblasts originating from the thigh
muscle of an adult female C3H mouse (Yaffe & Saxel, 1977), which is capable of rapid
differentiation and has contractile abilities similar to that of developing skeletal muscle
(Nedachi, Fujita, & Kanzaki, 2008). It is commonly utilized to mimic developing in utero
skeletal muscle due to similarities in gene expression and regulation of myogenic
processes between the cells and in vivo muscle (Burattini et al., 2004; Rajan et al., 2012).
C2C12 myoblasts (Group A), from passage 2 to 20, were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin/streptomycin until ~70-80% confluency was reached. Cells where then
induced to differentiate for 7 days into myotubes by supplementing media with 2% horse
serum (HS) and 1% penicillin/streptomycin instead of FBS. An additional subset of cells
was cultured with the addition of 110 mg/L sodium pyruvate in both the FBS and HS
DMEM media (Group B). All cells were incubated at 21% O2 and 5% CO2 (with N2
balance) at 37℃. After seven days of differentiation, cells were serum starved for five
hours to induce cell cycle synchronization (M. Chen et al., 2012). Cells and culture media
were then collected for mRNA, protein, and activity analysis.
A subset of cells was incubated with either 1uM or 10uM of PQQ (Sigma-Aldrich; CAS
number 72909-34-3) for the total seven days, final 48 hours, or final 5 hours of
differentiation. A further subset was exposed to 750uM or 1mM H2O2 (to simulate in
utero oxidative stress) (Figure 2.1-1)
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Figure 1.6.2-1 Cell Culture Model.
C2C12 myoblasts were differentiated for seven days to form myotubes. 1uM or 10uM of
PQQ was administered for all 7 days of differentiation, or the final 5H or 48H of
differentiation. 750uM or 1mM H2O2 was administered for the final 24H of
differentiation to induce oxidative stress.

2.2 Guinea Pig Model of Spontaneous IUGR
All animal procedures were conducted in accordance with the Canadian Council of
Animal Care guidelines. The Animal Use Protocol (AUP #2018-110) was approved by
the Western University Animal Care Committee. Time-mated pregnant Dunkin-Hartley
guinea pigs (Charles River Laboratories, Wilmington, MA) were housed on-site in
separate enclosures. Guinea pigs are an adequate model for human pregnancy due to
several anatomical and physiological similarities present throughout gestation. These
similarities including comparable progesterone levels, as well as sharing a
hemomonochorial placental structure which except the same mechanisms of spiral artery
remodeling. Finally, guinea pigs have longer pregnancies compared to other rodent
species, resulting in more mature neonates like humans (Harrell et al., 2017)
The animals were housed in a temperature and humidity-controlled environment, with a
12:12-hour light-dark cycle. Food (Guinea Pig Diet 5025; Lab Diet, St. Louis, MO) and
water were provided ad libitum. Food consumption, water consumption, and body weight
were measured daily, in addition to measuring litter size (Table 1).
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At mid-gestation (37 days; term ~69 days), dams were randomly assigned to either the
PQQ or control groups. For dams in the PQQ group, PQQ was administered in drinking
water a concentration of 1.5 mg/L. Given an average water consumption of 125
mL/kg/day, this concentration corresponds with an average dose of 0.18 mg
PQQ/day/kg/, a scaled equivalent of doses administered in other studies in mice and
humans (Harris et al., 2013; Jonscher, Stewart, Alfonso-Garcia, DeFelice, Wang, Luo,
Levi, Heerwagen, Janssen, de la Houssaye, et al., 2017). As stated, initial human studies
utilizing doses ranging from 0.2 – 0.3 mg PQQ/kg/day found that consumption of the
compound had a positive effect on reducing markers of inflammation and positively
promoting mitochondrial metabolism (Harris et al., 2013). Maternal PQQ consumption
did not significantly affect fetal or maternal parameters measured (Table 1 and 2).
Dams were euthanized by CO2 inhalation on gestational day 65. Following euthanasia,
fetuses were dissected from damns, weighed, and sex was determined. Brain-to-liver
weight ratio (BtL) was calculated to determine if a fetus was growth restricted or not.
Guinea pig pregnancies demonstrate spontaneous IUGR as a result of large litter sizes
and therefore no in utero manipulation was needed to induce said pregnancy
complication. Fetuses were classified as IUGR if BtL was >0.65 and fetal weight was
<80g, with fetuses outside both thresholds classified as normal growth (NG) (Table 2).
Placental weight and ratio to fetal weight was also measured (Table 2). Fetal male
gastrocnemius tissue was flash frozen in liquid N2 and stored at -80℃ for future analyses.
Gastrocnemius muscle was selected as it has both type I oxidative and type II glycolytic
fibers versus the relatively more oxidative muscle, the soleus.
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Table 1 Maternal Guinea Pig Characteristics
Group

Litter Size

Weight (g)

Food
Consumption

Water
Consumption

Control Water

4.667 ± 0.8819

1158 ± 198.7

51.73 ± 4.901

121.3 ± 25.47

PQQ Water

5.500 ± 0.2887

1350 ± 54.51

48.28 ± 3.054

107.6 ± 26.54

Data presented as mean ± SEM. Significance determined by two-way ANOVA; no
significant changes were observed.
Table 2 Fetal Guinea Pig Characteristics
Group

Fetal Weight (g)

Brain-to-Liver
Ratio

Placental
Weight (g)

Placental – to
– Fetal
Weight

Normal Growth
(NG)

102.641 ± 3.373

0.490 ± 0.040

4.991 ± 0.298

0.049 ± 0.002

Intrauterine Growth
Restriction (IUGR)

67.479 ± 4.288

0.848 ± 0.117

4.240 ± 0.636

0.062 ± 0.004

***

***

*

**

Normal Growth +
Maternal PQQ
Consumption
(NG/PQQ)

93.227 ± 4.987

0.535 ± 0.023

4.697 ± 0.339

0.049 ± 0.002

Intrauterine Growth
Restriction/Maternal
PQQ Consumption
(IUGR/PQQ)

71.883 ± 7.820

0.778 ± 0.068

3.813 ± 0.228

0.053 ± 0.003

***

***

*

**

Data presented as mean ± SEM. Significance determined by two-way ANOVA, *p<0.05,
**p<0.01, ***p<0.001.
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2.3 Rt-qPCR
Adherent C2C12 cells (Group A) were collected in Trizol reagent and stored at -80℃
before RNA isolation. Guinea pig gastrocnemius muscle was powered using a mortar and
pestle in liquid N2 and stored in Trizol reagent (Invitrogen) at -80℃. Both cell and
muscle samples were thawed, and 200 microliters of chloroform was added for every
1mL used during initial collection. Samples were briefly gently shaken by hand to
combine contents and then centrifuged for 15 minutes at 12000 x rcf at 4℃. The mixture
separated into a lower red phenol-chloroform phase, a middle interphase, and a colourless
upper aqueous phase. 400uL of the upper phase was removed and put into a new tube,
and then 500uL of isopropanol was additional added for every 1mL of Trizol used
initially. This new mixture was briefly vortexed prior to centrifugation at 12000 x rcf at
4℃ for 15 minutes. The supernatant was removed, leaving only the RNA pellet. The
pellet was washed by adding 1mL of 75% ethanol per 1mL of initial Trizol, then
centrifuged at 7500 x rcf for 10 minutes at 4℃. Samples were then stored at -20℃
overnight. The next day, the ethanol was removed, being careful not to disrupt the pellet,
and 1mL of new ethanol was added before centrifugation at 7500 x rcf for 10 minutes at
4℃. This step was repeated once more before removing all ethanol. The pellet was then
air-dried and dissolved in PCR-grade water. Samples were stored at -20℃ until further
analysis.
The quality and quantity of RNA yield was determined by the NanoDrop 2000
spectrophotometer (Thermo-Scientific). Quality was specifically measured using the
A260/280 ratio (≥1.8). To further ensure RNA quality, samples were separated on a
1.5% agarose gel stained with RedSafe in a formaldehyde buffer at 100V for 30 minutes.
Samples were screened for degradation by visualization using the Bio-Rad ChemiDoc
Imager of the 28S and 18S bands. Only samples without degradation (i.e., clear 28S and
18S bands) were used for future experiments.
Three micrograms of total RNA were used for reverse transcription using M-MLV
Reverse Transciptase (200U/uL) (ThermoFisher #28025013) in a 20-uL reaction volume.
In a nuclease-free microcentrifuge tube, 1uL of Oligo (dT)21 (40uM), 0.5uL of random
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primers (100uM), 1uL dNTP mix (10mM each dATP, dGTP, dCTP, and dTTP at neutral
pH) and 3 ug of total RNA were combined. Mixture was adjusted to a final volume of
13uL with RNase-free water and heated at 65℃ for 5 minutes before being chilled on ice.
Contents from tube were collected by brief centrifugation and 4uL of 5X First-Strand
Buffer and 2uL of DTT (0.1M) was added. Contents were gently mixed before incubation
at 37℃ for 2 minutes, after which 1uL of M-MLV RT (200 units) was added. A final
incubation at for 100 minutes at 37℃ occurred, and then the reaction was inactivated by
heating at 70℃ for a final 15 minutes.
Primer sets were designed using the NCBI Primer-Blast tool based on published Mus
musculus and Cavia porcellus sequences (Table 1 and 2). Primer fidelity was assessed by
performing a quantitative PCR (qPCR) reaction on a pooled cDNA sample using
SensiFastTM SYBR® No-ROX kit (FroggaBio) with Bio-Rad CFX384 detection system,
at 60℃ (primers were designed for a Tm of 60℃. DNA products were electrophoresed on
a 2% agarose gel stained with RedSafe dye in a TAE running buffer at 100V for 30
minutes. DNA products were visualized using Bio-Rad ChemiDoc Imager and only
primers with products of the predicted size were used. Primer efficiencies were measured
and only those with efficiency >90% were used for qPCR analysis.
qPCR was performed using the SensiFastTM SYBR® No-ROX kit (FroggaBio) on the
CFX 384 real-time PCR detection system (Bio-Rad) at a denaturing temperature of 95℃,
annealing temperature of 60℃, and elongation temperature of 75℃ for 40 cycles. A total
volume of 12uL in each well contained 2uL of diluted cDNA, 0.048uL of primer mix,
6uL of SYBR Green, and the remaining volume was filled with PCR-grade water. The
data was analyzed using the 2!∆∆#$ method (Livak and Schmittgen, 2001) using Hrpt,
Rsp12, Tubb, or Rpl13 as housekeeping genes (Masilamani, Loiselle, & Sutherland,
2014).
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Table 3 Mouse (Mus musculus) Primer Pairs
Gene

NCBI Accession #

Cox7a1

NM_009944.3

Hprt

NM_013556.2

Myod1

NM_010866.2

Myog

NM_031189.2

Ndufb6

NM_001033305.3

Pax7

NM_011039.2

Pgc-1𝛼

NM_008904.2

Rps12

NM_011295.6

Tfam

NM_009360.4

Strand

Sequence (5’ à 3’)

Forward

TCTTCCAGGCCGACAATGAC

Reverse

GCCCAGCCCAAGCAGTATAA

Forward

ATGGACTGATTATGGACAGGACTG

Reverse

TCCAGCAGGTCAGCAAAGAAC

Forward

TGCTCTGATGGCATGATGGATTA

Reverse

AGATGCGCTCCACTATGCTG

Forward

GAAGCGCAGGCTCAAGAAAG

Reverse

CGCGAGCAAATGATCTCCTG

Forward

CGTACCGCTCCAGTCTCTTC

Reverse

CCCTTAAGAGGGATGCTGCC

Forward

CGATTAGCCGAGTGTCTCAGA

Reverse

TCCAGACGGTTCCCTTTGTC

Forward

AAGGATGCGCTCTCGTTCAA

Reverse

CATAGCTGTCGTACCTGGGC

Forward

AAGGCATAGCTGCTGGAGGTGTAA

Reverse

AGTTGATGCGAGCACACACAGAT

Forward

TAGGCACCGTATTGCGTGAG

Reverse

GACAAGACTGATAGACGAGGGG
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Table 4 Guinea Pig (Cavia porcellus) Primer Pairs
Gene

NCBI Accession #

Atp5a1

XM_003474067.4

Atp5pb
𝛽-Tubulin/
Tubb

Cox4i2

Cox7a1

CS

Mhy1

Mhy2

Myh4

Myh7

XM_003479227.4

XM_003460999.4

XM_003476668.3

Strand

Sequence (5’ à 3’)

Forward

GCTGCCCAAACTAGGGCTAT

Reverse

GAGTGGCAGCATCGAGATCA

Forward

ACCCTACATGCTTGGAACTGG

Reverse

CGCTTCTGAACAAGTGCCTG

Forward

TGGTCGGCCTCTCAGAATCTT

Reverse

TTATCACCTCCCAGAACTTGGC

Forward
Reverse

XM_003467228.4

XM_003475969.4

XM_003466219.2

XM_003466220.3

XM_013148710.1

XM_003474485.3

Forward
Reverse
Forward

Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

CCACCAAATCAGCAAAGCCG
CATGCCGGATGAGCCTTTCT
CAGTGTGTGTCCTTGTCCGA
GGAGGTCATTGTTCTCCTTGGAA
GGCATATGCAGAGGGTGTCA
CCGATACTACTGCCCTCACG
GTGGACAAACTGCAAGCCAA
ATGTCTTTGGTCACTTTCCTGCAT
GGAGGAGGCTGAGGAACAAT
GTCTTGCTCTGGTCATTCCACA
GTAATTGCCTGCTTTGAGCCTG
TAGCTCCGCCTTCTGTCTTG
TTCCGAAAGGTGCAGCATGA
TTCCTCCCAAGGGGCTGTTA
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Myod1

XM_003465725.2

Myog

XM_003474821.2

Ndufb6

XM_003470823.4

Pax7

XM_003471164.2

Pgc-1𝛼

XM_003467408.4

Ppar- 𝛼

NM_001173004.1

Ppar-𝛿

XM_013156813.2

Ppar-𝛾

XM_003462736.4

Rpl13

XM_003461190.4

Sirt1

XM_013156679.2

Sirt3

XM_004999545.3

Tfam

XM_003473570.4

Ucp2

XM_013145311.2

Forward

TCCGACGGCATGATGGACTA

Reverse

GCTGTAATAGGCACCGTCGT

Forward

CCCAAGGTAGAGATCCTGCG

Reverse

TACATTCACTGGGCACCGTAG

Forward

GCCCCCGAATATTCCCAGGTG

Reverse

CATGGCTTAAAAGCCTTTGACATTT

Forward

GTGCCCTCAGTGAGTTCGAT

Reverse

GTCCAGTCGGTTCCCTTTGT

Forward

CCCAAGGGTTCCCCATTTGA

Reverse

CCCAAGGGTTCCCCATTTGA

Forward

AAGGCCTCAGGCTACCACTA

Reverse

CAGGTGAGGACTTCGGCTTT

Forward

CCAGCAGTTACACAGACCTCC
CCGTAGTGGAAGCCAGACG

Reverse
Forward
Reverse

CAATAGGCCTCACGAGGAGC
ATCCGCCCAAACCTGATGG

Forward

TCAATCAGCCAGCTCGGAAG

Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

GTGAATACCAGCCACCCGAA
TTGCAACTGCATCTTGCCTG
TCATGGGGTATGGAACTTG
TCCCCTGGAGGTGGAACCTTTT
CCAGCTGGAACAGAGAAGA
TGCGCTCACCTTTCAGTTTTG
TGTGCCAAAACTGCTCTCTCA
CGACGTGGTCAAGACGAG
AGGAGGGCATGAACCCTTTG
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2.4 Western Blots
2.4.1

Total Protein Extraction and Immunoblotting

Adherent C2C12 cells (Group A) were washed with cold PBS in the dish. Cold
radioimmunoprecipitation assay (RIPA) buffer, supplemented with protease and
phosphatase (1ug/mL leupeptin and aprotinin, 1mM PMSF, 1mM sodium orthovanadate,
2mM sodium fluoride) inhibitors, was utilized to extract total proteins from the cells;
cells were left in the buffer for 5 minutes before being scraped off plates with a plastic
policeman and collected. Cells were mixed by vortexing for 5 seconds and incubated on
ice for 5 minutes. Cells were further mixed by pipetting up and down 10 times then
sonicated at an amplitude of 30 for 5 seconds. Samples were lastly centrifuged at 16000 x
rcf at 4℃ for 10 minutes and supernatants were collected and stored at -20℃ for future
experiments.
Protein quantity was measured using the PierceTM BCA Protein Assay Reagent Kit
(ThermoFisher) and a microplate reader. 30ug of total protein was mixed with 5x
Laemmli sample buffer with 100uL beta-mercaptoethanol (BME), boiled for 5 minutes,
and loaded onto a hand-cast SDS-PAGE gel (4% stacking layer, 10-15% separating
layer). Gel electrophoresis was conducted at 70-75V until samples migrated through the
wells, then ran at 120-30V for 60-90 minutes in 1X running buffer. After proteins were
sufficiently separated, they were transferred from the SDS-PAGE gradient gels onto
polyvinylidene fluoride (PVDF) membranes (AmershamTM HybondTm P 0.2 um PVDF)
for 90-120 minutes at 100V using 1X transfer buffer. The membranes were Ponceau
stained, followed by a methanol rinse, then imaged with the Bio-Rad ChemiDoc Imager
to show efficient transfer, equal loading of protein, and allow for total protein
normalization (Figure 2.4.1-1).
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Figure 2.4.1-1 Representative Ponceau S Image
Ponceau S staining binds to protein transferred to PVDF membranes. Staining allows for
the determination the extent and success of the protein transfer that occurred, and visible
protein lanes can then be utilized for total protein normalization (Goldman, Harper, &
Speicher, 2016).
Following several washes in Tris-buffered saline with Tween 20 (TBS-T) to remove
Ponceau S stain, membranes were blocked in 5% milk or bovine serum albumin (BSA) in
TBS-T for 1 hour at room temperature. They were then incubated with primary
antibodies of 1:500-1:1000 dilutions in 5% milk or BSA at least overnight at 4℃ (Table
3). Following this incubation, the membranes were washed for 10 minutes, 3 separate
times, in TBS-T before incubation with secondary antibodies (mouse or rabbit; Table 3)
for one hour at room temperature
Following secondary antibody incubation, membranes were again washed in TBS-T three
times for 10 minutes. Using the electrochemiluminescent substrate Clarity MaxTM
(BioRad), total protein abundance was then visualized using the ChemiDoc Imaging
System (BioRad). Image Lab Software (BioRad) was employed to quantify protein
bands.

32

Table 4 Western Blot Antibody List
Antibody

Brand and Catalog #

Dilution

LDHA (C4B5)

Cell Signaling; #3582

1:1000

Abcam; ab110413

1:1000

PGC-1𝛼

ThermoFisher; PA5-38021

1:500

SIRT3 (D22A3)

Cell Signaling; #5490

1:1000

SOD2 (D9V9C)

Cell Signaling; #13194

1:1000

VDAC1/Porin [20B12AF2]

Abcam; ab14734

1:5000

Cell Signaling; #7074

1:10000

Cell Signaling; #7076

1:10000

OXPHOS
(ETC Complexes)

Rabbit Secondary
(Anti-rabbit IgG, HRPlinked)
Mouse Secondary
(Anti-mouse IgG, HRPlinked)

2.5 Activity Assays
2.5.1

Lactate Dehydrogenase Activity

Cell culture media was collected from PQQ and H2O2 treated cells from Group B after 19
hours of 1mM H2O2 exposure. Media samples were frozen at -80℃ until utilized. Lactate
dehydrogenase (LDH) activity within the samples was then measured using the
colorimetric LDH Assay Kit (Abcam; CAT ab102526). In brief, 40uL of media was
mixed with 10uL of assay buffer and plated in duplicate. A 1.25mM reduced
nicotinamide adenine dinucleotide (NADH) standard curve dilution was also prepared
according to the manufacturer’s instructions to generate a curve composed of 0, 2.5, 5,
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7.5, 10, and 12.5 nmol/well, plated in duplicate. 50uL of reaction mix (48uL of LDH
Assay Buffer, 2uL LDH substrate mix) was added to each well with sample and standard,
then the plate was mixed well. Using a microplate reader, the OD at 450nm was
measured kinetically every 2-3 minutes for 60 minutes at 37℃, protected from light.
Total protein concentration within the media was also measured and used to normalize
the LDH concentration within each sample. Total LDH activity was expressed in mU/mL
relative to total protein.

2.5.2

Superoxide Dismutase Activity

Adherent C2C12 (Group B) were washed with cold PBS before being scraped off the
plate using a plastic policeman. Collected cells were centrifuged at 1000 x g for 10
minutes at 4°C. The cell pellet was then homogenized in a cold 20mM HEPES buffer, pH
7.2 (containing 1mM EGTA, 210mM mannitol, 70mM sucrose) before being centrifuged
at 1500 x g for 5 minutes at 4°C. The supernatant containing total SOD (cytosolic and
mitochondrial) was collected and stored at -80°C or centrifuged at 10000 x g for 15
minutes at 4°C to separate cytosolic SOD from mitochondrial SOD. The supernatant
containing cytosolic SOD was then removed and stored at -80°C for future analysis. The
remaining mitochondrial SOD pellet was homogenized in the cold buffer (20mM HEPES
buffer, pH 7.2, containing 1mM EGTA, 210mM mannitol, 70mM sucrose) and stored at 80°C for future analysis.
SOD activity within the samples was then measured using the colorimetric SOD Assay
Kit (Cayman Chemical; Item No. 706002) and protocol. In brief, 10uL of sample, plated
in triplicate, was mixed with 200uL of diluted Radical Detector (Cayman Chemical; Item
No. 706004) in 96-well plate. 20uL of SOD Standard (Cayman Chemical; Item No.
706005) with 1.98mL of dilute Sample Buffer (Cayman Chemical; Item No. 706003) was
mixed to produce a 0 to 0.050 U/mL final SOD activity standard curve. Reaction was
initiated by adding 20uL of diluted Xanthine Oxidase to all wells in use. The addition of
potassium cyanide to a final concentration of 1-3mM to wells containing mitochondrial
SOD samples to inhibit any residual cytosolic SOD. After mixing, the plate was
incubated for 30 minutes at room temperature then the absorbance was read at 440-
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460nm using a plate reader. Protein concentration of the samples was tested and used as
an internal control to normalize the SOD concentration in the samples. Total SOD
activity was expressed as U/mL relative to total protein.

2.5.3

Catalase Activity

Adherent C2C12 (Group B) were washed with cold PBS before being scraped off the
plate using a plastic policeman. Collected cells were centrifuged at 1000 x g for 10
minutes at 4°C. The cell pellet was then homogenized in a cold 50mM potassium
phosphate buffer, pH 7.0 (containing 1mM EDTA) before being centrifuged at 10000 x g
for 15 minutes at 4°C. The supernatant was collected and stored at -80°C for future
analysis.
CAT activity within the sample was then measured using the colorimetric Catalase Assay
Kit (Cayman Chemical; Item No. 707002) and protocol. In brief, 10uL of Catalase
Formaldehyde Standard (Cayman Chemical; Item No. 707014) with 9.99 mL of diluted
Sample Buffer (Cayman Chemical; Item No. 707012) to obtain a 4.25 formaldehyde
stock solution. This solution was further diluted to produce a standard curve with final
concentration ranging from 0-75uM formaldehyde, plated in duplicate. Each standard
well contained 100uL of diluted Assay Buffer (Cayman Chemical; Item No. 707010),
30uL of methanol, and 20uL of standard. Sample wells contained 100uL of the same
diluted Assay Buffer, 30uL of methanol, and 20uL of sample, plated in duplicate. To
initiate the reaction, 20uL of diluted hydrogen peroxide was added to all utilized wells,
and then the plate was covered and shaken for 20 minutes at room temperature. 30uL of
potassium hydroxide was then added to each well to terminate the reaction, followed by
30uL of Catalase Purpald (Cayman Chemical; Item No. 707017). The plate was again
covered and shaken for 10 minutes at room temperature before addition of 10uL of
potassium periodate (Cayman Chemical; Item No. 707018). The plate was covered and
shaken one final time for 5 minutes at room temperature before the absorbance was read
at 540 nm. Protein concentration of the samples was tested and used as an internal control
to normalize the CAT concentration in the samples. Total CAT activity was expressed as
nmol/min/mL relative to total protein.
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2.6 Statistics
GraphPad Prism 9 was used for all statistical analyses. All data is presented in boxwhisker plots, representing the median 25th and 75th quartiles, and minimum/maximum
values. In vitro (I.e., in C2C12 myoblasts) enzyme activity, as well protein and gene
expression were analyzed using a one-way ANOVA with a Dunnett’s multiple
comparisons test. In vivo (I.e., in fetal guinea pig muscle) gene expression was analyzed
by two-way ANOVA and Tukey’s multiple comparisons test. A p value of less than 0.05
was considered significant. Values were determined to be outliers if they were more than
two standard deviations away from the mean.
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3

Results

3.1 Effects of H2O2 and PQQ on LDH, CAT, and SOD
activity and total protein abundance
3.1.1

LDH Activity and Total Protein Abundance

LDH activity within the cell culture media of developing in vitro myotubes was not
significantly affected by acute 1mM H2O2 exposure. Similarly, 1uM and 10uM PQQ
exposure alone did not significantly affect LDH activity within the media (Figure 3.1.11). Lastly, 1um and 10uM PQQ alone did not affect total LDHA protein abundance at
any time point (Figure 3.1.1-2).
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Figure 3.1.1-1 LDH Activity with the cell media of developing in vitro myotubes.
LDH activity is a measure of the relative cytotoxicity that has occurred within the cells.
Relative to control, 19H 1mM H2O2 exposure before collection did not affect LDH
activity. Similarly, short-term, and long-term exposure of either low dose 1uM or high
dose 10uM PQQ alone did not affect LDH activity relative to control. N=3-4. Data
presented as means ± SEM (significance determined by one-way ANOVA and Dunnett’s
multiple comparisons test, no significant differences were observed).
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Treatment Groups

LDHA
~ 37 kDa

Figure 3.1.1-2 Relative total protein abundance of LDHA in developing in vitro
myotubes.
LDHA is an enzyme involved in anaerobic metabolism. 1uM and 10uM PQQ for a shortterm or long-term exposure time in developing myotubes did not affect total protein
abundance of LDHA. N=3-4. Data presented as means ± SEM (significance determined
by one-way ANOVA and Dunnett’s multiple comparisons test, no significant differences
were observed).
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3.1.2

SOD Activity

Total SOD activity within developing in vitro myotubes was not significantly affected by
acute 1mM H2O2 exposure nor 1mM H2O2 in combination with PQQ (Figure 3.1.2-1A).
PQQ alone did not result in a change in activity relative to control (Figure 3.1.2-1B).
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Figure 3.1.2-1 Relative total SOD activity in developing in vitro myotubes.
SOD activity is associated with dismutation of superoxide. (A) Relative to control, 24H
1mM H2O2 exposure did not significantly affect SOD activity, including PQQ + H2O2
exposure (B) Short term and long-term exposure of either 1uM or 10uM PQQ alone did
not affect activity relative to control. N=3-4. Data presented as means ± SEM
(significance determined by one-way ANOVA and Dunnett’s multiple comparisons test,
no significant differences were observed).
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Figure 3.1.2-2 Relative total protein abundance of SOD2 in developing in vitro
myotubes.
SOD2 is the mitochondrial SOD (also referred to as MnSOD) antioxidant responsible for
the dismutation of H2O2. 1uM and 10uM PQQ for short-term or long-term exposure in
developing myotubes did not affect total protein abundance of SOD2. N=3-4. Data
presented as means ± SEM (significance determined by one-way ANOVA and Dunnett’s
multiple comparisons test, no significant differences were observed).

40

3.1.3

CAT Activity

Total CAT activity within developing in vitro myotubes was not significantly affected by
acute 1mM H2O2 exposure nor by 1mM H2O2 in combination with any exposure length
or dose of PQQ (Figure 3.1.3-1A). Similarly, 1uM and 10uM PQQ exposure alone did
not significantly affect total CAT activity relative to control (Figure 3.1.3-1B).
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Figure 3.1.3-1 Relative CAT activity in developing in vitro myotubes.
CAT activity is associated with the breakdown of H2O2. (A) Relative to control, 24H
1mM H2O2 exposure did not significantly affect SOD activity, including PQQ + H2O2
exposure. (B) Short term and long-term exposure of either 1uM or 10uM PQQ alone did
not affect CAT activity relative to control. N=3-4. Data presented as means ± SEM
(significance determined by one-way ANOVA and Dunnett’s multiple comparisons test,
no significant differences were observed).
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3.2 Choosing an Effective Dose of H2O2 in Group A Cells
Concentrations ranging from 200uM to 1mM of H2O2 have been shown to induce OS
within C2C12 cells (Li et al., 2020). After exposure of Group A cultured myoblasts to
H2O2 concentrations ranging from 250uM to 1mM for 24 hours, qualitative analysis of
cell morphology was conducted. 1mM H2O2 significantly altered the number of living
cells, compared to control and other concentrations of H2O2, so the concentration was
deemed too cytotoxic to be utilized in future experiments. The next highest concentration
750uM was therefore chosen to induce OS in subsequent experiments with Group A cells
(Figure 3.1.3-1).

Figure 3.1.3-1 Relative cytotoxicity of varying concentrations of H2O2 in
differentiating in vitro myoblasts.
Within cultured C2C12 cells, concentrations ranging from 200uM to 1mM of H2O2 have
been shown to induce OS within the developing myotubes. After 24H exposure to 1mM
H2O2, 1mM was determined qualitatively to be too cytotoxic and resulted in significant
cell death. The next highest concentration, 750uM, which did not appear to be
significantly cytotoxic to the cells, was chosen to induce OS in differentiating myotubes
in subsequent experiments.
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3.3 H2O2 and PQQ negatively affected gene expression of
markers of mitochondrial function and myogenesis but
not total protein abundance
3.3.1

Mitochondrial Function

Ndufb6, Cox7a1, and Tfam expression within in vitro developing myotubes was
significantly decreased (p<0.05) as a result of 24H 750uM H2O2 exposure (Figure 3.3.11A, Figure 3.3.1-2A, and Figure 3.3.1-4A), while relative Pgc-1𝛼 was not affected,
compared to control (Figure 3.3.1-3A). Next, both 1uM and 10uM PQQ supplementation
at all timepoints (5H, 48H, 7D) did not rescue expression when paired with H2O2
exposure, as a significant decrease (p<0.001) in Ndufb6 and Cox7a1 expression
continued to be evident (Figure 3.3.1-1A and Figure 3.3.1-2A), whereas no combination
of exposure length and PQQ doses with H2O2 significantly changed PGC-1𝛼 or Tfam
expression (Figure 3.3.1-3A and Figure 3.3.1-4A). Similar to the effects of H2O2
exposure, 1uM and 10uM PQQ alone at the 5H, and 48H timepoints significantly
decreased (p<0.01) expression of Ndufb6 (Figure 3.3.1-1B), and both concentrations at
the 7D timepoint significantly decreased (p<0.01) expression of both Ndufb6 and Cox7a1
(Figure 3.3.1-1B and Figure 3.3.1-2B), while overall PQQ alone did not affect Pgc-1𝛼 or
Tfam expression (Figure 3.3.1-3B and Figure 3.3.1-4B). Finally, no dose or length of
exposure of PQQ or H2O2, nor the combination of the two, affected the total protein
abundance of complexes I, II, III, and V (Figure 3.3.1-5A-H), and PQQ alone did not
affect VDAC1 (Figure 3.3.1-6), PGC-1𝛼 (Figure 3.3.1-7A) or SIRT3 (Figure 3.3.1-7B)
total protein abundance within the myotubes.
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Figure 3.3.1-1 Relative mRNA expression of Ndufb6 in developing in vitro myotubes.
NADH:ubiquinone oxidoreductase (complex I) of the ETC expresses Ndufb6. (A)
Relative to control, 24H 750uM H2O2 exposure significantly decreased Ndufb6
expression and neither 1uM nor 10uM PQQ exposure rescued expression at any
timepoint. (B) Short-term and long-term exposure of either 1uM or 10uM PQQ alone
significantly decreased expression of Ndufb6, relative to control. N=3-4. Data presented
as means ± SEM (significance determined by one-way ANOVA and Dunnett’s multiple
comparisons test, ***p<0.001).
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Figure 3.3.1-2 Relative mRNA expression of Cox7a1 in developing in vitro myotubes.
Cytochrome c oxidase (complex IV) of the ETC expresses Cox7a1. (A) Relative to
control, 24H 750uM H2O2 significantly decreased Cox7a1 expression and neither 1uM or
10uM PQQ exposure rescued expression at any timepoint. (B) Long-term exposure of
either 1uM or 10uM PQQ alone significantly decreased expression of Cox7a1, relative to
control. N=3-4. Data presented as means ± SEM (significance determined by one-way
ANOVA and Dunnett’s multiple comparisons test, **** p<0.0001).

45

A.

Relative Expression

2.5
2.0
1.5
1.0
0.5

uM
10
7D

7D

+

+

2O
2

2O
2

H

H

H

+
2O
2

2O
2

H

1u
M

uM
48

48

H

H

10

1u
M

uM
+

+
2O
2

H

H

2O
2

+

5H

5H

10

1u
M

2O
2

H

C

on
tr

ol

0.0

Treatment Groups

B.
2.5
2.0
1.5
1.0
0.5

uM
7D

10

M
1u
7D

uM
48

H

10

M
1u
H
48

uM
5H

10

M
1u
5H

C

on
tr

ol

0.0

Figure 3.3.1-3 Relative mRNA expression of Pgc-1𝜶 in developing in vitro myotubes.
Pgc-1𝛼 expression is associated with mitochondrial biogenesis. (A) H2O2 alone nor in
combination with PQQ at any timepoint or dose affected expression of Pgc-1𝛼, relative to
control. (B) No dose or time-point of PQQ exposure alone resulted in a significant effect
to Pgc-1𝛼 expression, relative to control. N=3-4. Data presented as means ± SEM
(significance determined by one-way ANOVA and Dunnett’s multiple comparisons test;
no significant changes were observed).
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Figure 3.3.1-4 Relative mRNA expression of Tfam in developing in vitro myotubes.
Tfam expression induces mitochondrial DNA transcription. (A) Relative to control, 24H
750uM H2O2 exposure significantly decreased Tfam expression and neither 1uM nor
10uM PQQ exposure rescued expression at any timepoint. (B) No concentration or timepoint of PQQ exposure alone resulted in a significant effect to Tfam expression, relative
to control. N=3-4. Data presented as means ± SEM (significance determined by one-way
ANOVA and Dunnett’s multiple comparisons test; *p<0.05).
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NDUFB8
~ 20 kDa
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~ 20 kDa

UQCRC2
~ 48 kDa
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~ 48 kDa

SDHB
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SDHB
~ 30 kDa

ATP5A
~ 55 kDa

ATP5A
~ 55 kDa

Figure 3.3.1-5 Total protein abundance of ETC complexes (I, II, III, V) in
developing in vitro myotubes.
NADH: ubiquinone oxidoreductase (complex I) expresses NDUFB8, succinate
dehydrogenase (complex II) expresses SDHB, coenzyme Q: cytochrome c reductase
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(complex III) expresses UQCRC2, and ATP Synthase (complex V) expresses ATP5A.
(A-D) Neither 24H 750UM H2O2 or 1uM/10uM PQQ exposure alone, nor H2O2 in
combination with PQQ, at any timepoint or concentration, affected total protein
abundance of (A,B) NDUFB8, (C,D) SDHB, (E,F) UQCRC2, or (G,H) ATP5A, relative
to control. N=3-6. Data presented as means ± SEM (significance determined by one-way
ANOVA and Dunnett’s multiple comparisons test, no significant changes were
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VDAC1
~ 37 kDa
Figure 3.3.1-6 Total protein abundance of VDAC1 in developing in vitro myotubes.
VDAC1 expression is associated with apoptosis regulation within the mitochondria and is
commonly utilized as a marker of mitochondria number. Neither 24H 750uM H2O2 nor
H2O2 in combination with PQQ, at any timepoint or concentration, affected total protein
abundance of VDAC1 relative to control. PQQ alone did not affect VDAC1 compared to
control. N=3-4. Data presented as means ± SEM (significance determined by one-way
ANOVA and Dunnett’s multiple comparisons test, no significant changes were
observed).
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Figure 3.3.1-7 Total protein abundance of PGC-1𝜶 and SIRT3 in developing in vitro
myotubes.
PGC-1𝛼 and SIRT3 expression are associated with mitochondrial biogenesis. (A) PQQ
alone did not affect PGC-1𝛼 compared to control. (B) PQQ alone did not affect SIRT3
compared to control. N=3-4. Data presented as means ± SEM (significance determined
by one-way ANOVA and Dunnett’s multiple comparisons test, no significant changes
were observed).
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3.3.2

Myogenesis

In vitro myotube Pax7 expression was not significantly affected by 24H 750uM H2O2
exposure, nor any combination of H2O2 and PQQ during differentiation, relative to
control (Figure 3.3.2-1A and Figure 3.3.2-1B). In comparison, myotube expression of
Myod1 and Myog was significantly decreased (p< 0.001) as a result of H2O2 exposure,
and all combinations of PQQ and H2O2, relative to control (Figure 3.3.2-2A and Figure
3.3.2-3A). Pax7 expression was significantly affected by PQQ, in that all doses and
exposure timepoints (except 5H 1uM and 7D 1uM) significantly decreased (p<0.05)
expression relative to control (Figure 3.3.2-1B). Lastly, 1uM and 10uM PQQ alone for
7D significantly decreased (p<0.05) expression of Myod1 (Figure 3.3.2-2B), while all
timepoints and doses studied did not significantly affect Myog expression within the
myotubes (Figure 3.3.2-3B).
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Figure 3.3.2-1 Relative mRNA expression of Pax7 in developing in vitro myotubes.
Pax7 expression is associated with proliferation during myogenesis and overall
regenerative capacity of the skeletal muscle. (A) 24H 750uM H2O2 alone nor in
combination with low and high dose PQQ at any timepoint affected expression of Pax7,
relative to control. (B) Exposure to 1uM and 10uM PQQ alone, for short-term and longterm durations, significantly decreased expression, relative to control. N=3-4. Data
presented as means ± SEM (significance determined by one-way ANOVA and Dunnett’s
multiple comparisons test; *p<0.05, **p<0.01).
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Figure 3.3.2-2 Relative mRNA expression of Myod1 in developing in vitro myotubes.
Myod1 expression is associated with differentiation of myofibers during myogenesis. (A)
Relative to control, 24H 750uM H2O2 significantly decreased Myod1 expression and
neither 1uM nor 10uM PQQ exposure rescued expression at any timepoint. (B) Longterm 1uM and 10uM exposure to PQQ alone significantly decreased expression of
Myod1 relative to control in the developing myotubes. N=3-4. Data presented as means
± SEM (significance determined by one-way ANOVA and Dunnett’s multiple
comparisons test; *p<0.05, ****p<0.0001).
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Figure 3.3.2-3 Relative mRNA expression of Myog in developing in vitro myotubes.
Myog expression is associated with differentiation during myogenesis. (A) Relative to
control, 24H 750uM H2O2 significantly decreased myotube Myog expression and neither
1uM nor 10uM PQQ exposure significantly rescued expression at any timepoint. (B)
Exposure to PQQ alone did not affect expression of Myog, relative to control. N=3-4.
Data presented as means ± SEM (significance determined by one-way ANOVA and
Dunnett’s multiple comparisons test; ***p<0.001).
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3.4 IUGR and Maternal PQQ Exposure Significantly
Impacted Gastrocnemius mRNA Expression
3.4.1

Myogenesis

Expression of fetal gastrocnemius muscle Pax7 mRNA was significantly decreased in
association with IUGR (F1,13 = 6.799, p<0.05) and maternal PQQ consumption (F1,13 =
36.03, p<0.01); expression was significantly decreased in NG/PQQ and IUGR/PQQ
animals, compared to NG water control animals. Myod1 expression was significantly
decreased in association with IUGR (F1,13 = 45.27, p<0.0001) and maternal PQQ
consumption (F1,13 = 17.50, p<0.01). A significant interaction between variables was also
observed (F1,13 = 6.722, p<0.05) and IUGR (p<0.001), NG/PQQ (p<0.01), and
IUGR/PQQ animals (p<0.0001) had variable decreases in expression compared to NG
water control animals. IUGR/PQQ (p<0.05) was also associated with a significant
decrease in Myod1 expression, compared to NG/PQQ animals. Lastly, Myog expression
within the muscle was decreased in association with IUGR (F1,13 = 16.37, p<0.01) and
maternal PQQ consumption (F1,13 = 25.34, p<0.001), with IUGR, NG/PQQ, and
IUGR/PQQ animals having lower expression compared to NG water control animals as
well (Figure 3.4.2-1).

3.4.2

Fiber Type Composition

Expression of Myh7 (type 1a; slow oxidative) was significantly decreased in association
with IUGR (F1,13 = 4.880, p <0.05) and maternal PQQ consumption (F1,13 = 7.267,
p<0.05); expression was lower in IUGR/PQQ animals compared to NG water control
animals. Expression of Myh2 (type 2a; fast oxidative)was significantly decreased in
association with only maternal PQQ consumption (F1,13 = 12.89, p<0.01) with expression
being lower in IUGR/PQQ animals compared to NG water control animals. Expression of
Myh4 (type 2b; fast glycolytic) was significantly decreased in association with both
IUGR (F1,13 = 22.67, p<0.001) and maternal PQQ consumption (F1,13 = 7.755, p<0.05),
with IUGR, NG/PQQ, and IUGR/PQQ animals having decreased expression compared to
NG water control animals. Lastly, expression of Myh1 (type 2x; fast oxidative) was

55

significantly decreased in conjunction with IUGR (F1,13 = 20.44, p<0.001), as expression
was lower in IUGR and IUGR/PQQ animals compared NG water control animals (Figure
3.4.2-2).
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3Figure 3.4.2-1 Relative mRNA expression of Pax7, Myod1, and Myog in fetal
gastrocnemius tissue.
Relative mRNA expression of myogenesis markers in NG or IUGR fetal guinea pig
gastrocnemius muscle exposed to control or PQQ-addition maternal water consumption.
Proliferating myoblasts express Pax7, while differentiated myofibers express Myod1 and
Myog. IUGR alone negatively affected Pax7, Myod1 and Myog expression, relative to
control. PQQ negatively affected Pax7, Myod1, and Myog expression as well. An
interaction effect on Myod1 was also observed. N=4-5. Data presented as means ± SEM
(significance determined by two-way ANOVA and Tukey’s multiple comparisons test,
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).
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Figure 3.4.2-2 Relative mRNA expression of Myh7, Myh2, Myh4, and Myh1 in fetal
gastrocnemius tissue.
Relative mRNA expression of myosin heavy chain genes (MHC) in NG or IUGR fetal
guinea pigs exposed to control or PQQ-addition maternal water consumption is shown.
Slow oxidative fibers express Myh7, while fast oxidative fibers, types IIa and IIx, express
Myh2 and Myh1, respectively. Fast glycolytic fibers, type IIb express Myh4. IUGR
negatively affected Myf7, Myf4, and Myf1 expression. PQQ negatively affect Myf7,
Myf2, and Myf4 expression. N=4-5. Data presented as means ± SEM (significance
determined by two-way ANOVA and Tukey’s multiple comparisons test, *p<0.05,
**p<0.01, ***p<0.001).
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Figure 3.4.2-3 Summary of the relative mRNA expression of myogenic genes in
developing in vitro myotubes and fetal gastrocnemius muscle.
Based on treatment group, the downward arrows represent a significant decrease in
relative mRNA expression, while the circles represents that no significant change in
expression was observed for each corresponding myogenic gene.
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3.4.3

Electron Transport Chain

Ndufb6 expression was significantly decreased in association with IUGR (F1,13 = 38.87,
p≤0.0001), as expression in IUGR and IUGR/PQQ animals was decreased relative to NG
water control animals. Similarly, Cox7a1 and Cox4i2 (complex IV subunits) expression
was significantly decreased in association with IUGR (F1,13 = 68.92, p<0.0001; F1,13 =
49.34, p<0.0001); IUGR/CTRL and IUGR/PQQ animals had lower expression of both
genes, compared to NG water control animals. As well, Atp5a1 (complex V subunit)
expression and Atp5pb (complex V subunit) expression had significantly decreased
expression in conjunction with both IUGR ((F1,13 = 63.95, p<0.0001; F1,13 = 45.33,
p<0.0001), with decreased expression in IUGR and IUGR/PQQ animals relative to NG
water control animals too. Lastly, CS expression was significantly decreased in
association with IUGR (F1,13 = 39.73, p<0.0001) and maternal consumption of PQQ
((F1,13 = 5.453, p<0.05), with decreased expression observed in IUGR, NG/PQQ, and
IUGR/PQQ animals, compared to NG water control animals (Figure 3.4.4-1).

3.4.4

Mitochondrial Biogenesis and Fatty Acid Oxidation

Pgc-1𝛼 expression was significantly decreased in association with IUGR (F1,13 = 25.20,
p<0.001), and maternal PQQ consumption (F1,13 = 12.46, p<0.01), in addition to an
observed significant interaction effect (F1,13 =5.616, p<0.05), with IUGR (p<0.01),
NG/PQQ (p<0.01), and IUGR/PQQ (0.001) animals exhibited varying decreases in
expression, relative to NG water control animals. Sirt1 expression was significantly
decreased in association with both IUGR (F1,13 = 12.21, p<0.01) and maternal PQQ
consumption (F1,13 = 8.489, p<0.05); IUGR and IUGR/PQQ animals had lower
expression compared to NG water control animals. Related Sirt3 was also significantly
decreased in association with IUGR (F1,13 = 68.11, p<0.0001), and PQQ (F1,13 = 20.57,
p<0.001), in addition to an observed significant interaction (F1,13 = 4.689, p<0.05), with
IUGR (p<0.001), NG/PQQ (p<0.01), and IUGR/PQQ (p<0.0001) animals demonstrating
varying decreases in expression relative to NG water control animals. A significant
decrease was also observed in Sirt3 expression IUGR/PQQ animals (p<0.01), compared
to NG/PQQ animals. Tfam expression was significantly decreased by IUGR (F1,13 =
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54.80, p<0.0001) only; expression was decreased in IUGR and IUGR/PQQ animals,
compared to NG water control animals and NG/PQQ animals. Cpt-1𝛽 expression was
significantly decreased in conjunction with IUGR (F1,13 = 24.29, p<0.001) and maternal
PQQ consumption (F1,13 = 4.849, p<0.05), with IUGR and IUGR /PQQ animals showing
lower expression relative to NG water control animals (Figure 3.3.4-1). Lastly, Ucp2
expression was significantly decreased in association with IUGR (F1,13 = 30.06, p<0.001)
and maternal PQQ consumption (F1,13 = 6.122, p<0.05); only IUGR and IUGR/PQQ
animals show decreased expression compared to NG water control animals, and
IUGR/PQQ was decreased relative to NG/PQQ animals too (Figure 3.4.4-2).
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Figure 3.4.4-1 Relative mRNA expression of ETC complexes and citrate synthase in
fetal gastrocnemius muscle.
Relative mRNA expression of electron transport chain (ETC) complexes and citrate
synthase in NG or IUGR fetal guinea pigs exposed to control or PQQ-addition maternal
water consumption is shown. NADH: ubiquinone oxidoreductase (complex I) expresses
Ndufb6, cytochrome c oxidase (complex IV) expresses Cox7a1 and Cox4i2, and ATP
Synthase (complex V) expresses Atp5a1 and Atp5pb. Citrate synthases expresses CS.
IUGR negatively affected all genes studied, while CS expression was also affected by
PQQ. N=4-5. Data presented as means ± SEM (significance determined by two-way
ANOVA and Tukey’s multiple comparisons test, *p<0.05, ****p<0.0001).
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Figure 3.4.4-2 Relative mRNA expression of markers of mitochondrial metabolism
and fatty acid oxidation in fetal gastrocnemius muscle.
Relative mRNA expression of mitochondrial metabolism and fatty acid oxidation
markers in NG or IUGR fetal guinea pigs exposed to control or PQQ-addition maternal
water consumption are shown. Pgc-1𝛼, Sirt1, and Sirt3 are expressed during regulation of
cellular metabolism involving the mitochondria. Tfam expression induces mitochondrial
DNA transcription. Cpt-1𝛽 expression increases during fatty-acid oxidation in skeletal
muscle. IUGR and PQQ negatively affected all genes studied, compared to control,
except for Tfam expression, which was only negatively affected in association with
IUGR. N=4-5. Data presented as means ± SEM (significance determined by two-way
ANOVA and Tukey’s multiple comparisons test, *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001).
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Figure 3.4.4-3 Relative mRNA expression of Ucp2 in fetal gastrocnemius muscle.
Relative mRNA expression of Ucp2 in NG or IUGR fetal guinea pigs exposed to control
or PQQ-addition maternal water consumption is shown. Ucp2 uncouples oxygen from
mitochondrial ATP synthesis and is associated with the reduction of OS in the
mitochondria. IUGR and PQQ negatively affected expression. N=4-5. Data presented as
means ± SEM (significance determined by two-way ANOVA and Tukey’s multiple
comparisons test, *p<0.05, ***p<0.001).
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3.4.5

Peroxisome Proliferator-Activated Receptors

Ppar-𝛼 was significantly decreased by IUGR (F1,13 = 58.26, p<0.0001), maternal PQQ
intake (F1,13 = 23.64, p<0.001), and a significant interaction was evident (F1,13 = 8.448,
p<0.05), as decreased expression was evident in IUGR (p<0.0001), NG/PQQ (p<0.001),
and IUGR/PQQ animals (p<0.0001), compared to NG water control animals.
Additionally, a significant decrease in IUGR/PQQ (p<0.05) animals compared to
NG/PQQ animals was observed too. Ppar-𝛿 expression was significantly decreased in
association IUGR (F1,13 = 16.45, p<0.01) and maternal PQQ consumption (F1,13 = 13.22,
p<0.01) too; IUGR, NG/PQQ, and IUGR/PQQ animals all demonstrating decreased
expression, relative to NG water control animals. Finally, Ppar-𝛾 expression was
significantly decreased in association with IUGR (F1,13 = 14.98, p<0.01) and maternal
PQQ consumption (F1,13 = 8.671, p<0.05), and only IUGR/CTRL and IUGR/PQQ
animals show decreased expression compared to NG water control animals (Figure 3.4.51).
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Figure 3.4.5-1 Relative mRNA expression of Ppar-𝒂,𝜹, and 𝜸 in fetal gastrocnemius
muscle.
Relative mRNA expression of PPARs in NG or IUGR fetal guinea pigs exposed to
control or PQQ-addition maternal water consumption is shown. Ppar-𝑎 expression
regulates overall energy homeostasis, while Ppar-𝛾 expression is involved in glucose
metabolism. Ppar-𝛿 expression is important for fatty acid metabolism. IUGR and PQQ as
negatively affected all 3 genes, compared to control. N=4-5. Data presented as means ±
SEM (significance determined by two-way ANOVA and Tukey’s multiple comparisons
test, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).
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Figure 3.4.5-2 Summary of the relative mRNA expression of genes involved in
cellular metabolism in developing in vitro myotubes and fetal gastrocnemius muscle.
Based on treatment group, the downward arrows represent a significant decrease in
relative mRNA expression, while the circles represents that no significant change in
expression was observed for each corresponding metabolic gene.
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4

Discussion

4.1 Impact of Hydrogen Peroxide and PQQ on Antioxidant
Enzymes’ Total Protein Abundance and Activity
4.1.1

Studying OS and PQQ using H2O2 and LDH Activity/Total
Protein Abundance

Exogenous H2O2 is utilized to induce OS within cell culture systems to study the insult’s
negative effects, as well as possible preventative treatments (Bosutti & Degens, 2015;
Konyalioglu, Armagan, Yalcin, Atalayin, & Dagci, 2013). OS promotes the degradation
of cellular membranes, resulting in the release of lactate dehydrogenase (LDH) in the
extracellular space (Jovanović et al., 2010). Measuring the LDH activity within cell
culture media, including that of C2C12 cells (Lin Tan, Shavlakadze, Grounds, & Arthur,
2015), can therefore can be utilized to determine the relative level of cytotoxicity induced
by models of OS, as a proxy measurement of membrane damage (Kaja, Payne,
Naumchuk, & Koulen, 2017).
Acute H2O2 exposure at concentrations as little as 100 uM has been shown to increase
LDH activity within cell culture media (Hong & Liu, 2004; Wijeratne, Cuppett, &
Schlegel, 2005), but this result was not replicated in the present study. Instead, 19H
exposure to 1mM of H2O2 did not significantly affect LDH within the media of the
differentiated myotubes. More recent research provides a possible explanation for this
finding, as it was shown that 1mM H2O2 can actually inhibit the activity of LDH isolated
from rabbit muscle (suspended in PBS) after only 1H of direct exposure (Kendig &
Tarloff, 2007). It could therefore be postulated that even if OS was present within the
cells and LDH was released into the media, that enzyme activity would not be increased
due to presence of H2O2 within the media as well.
Secondly, PQQ at concentrations below 30uM has been shown to function as an
antioxidant, while concentrations above 30uM have been associated with pro-oxidant
effects in several cell types including those derived from the liver and adrenal glands (He
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et al., 2003; J. Kim, Harada, Kobayashi, Kobayashi, & Sode, 2010; Wu, Pan, Shen, &
Xing, 2018). In support of these studies, neither 1uM nor 10uM PQQ at any timepoint
studied (5H, 48H, 7D) resulted in a significant change in LDH activity within collected
media, similar to control and H2O2 treatments. Though, it is again important to consider
the possible inhibition of LDH by H2O2 when interpreting these results, as PQQ has been
shown to interact with culture media and produce H2O2, though the production
mechanisms are unclear (He et al., 2003). It has been suggested that oxidation of reduced
PQQ is the mechanisms associated with downstream H2O2 production (Mukai, Ouchi,
Nagaoka, Nakano, & Ikemoto, 2016).
Furthermore, more recent research has suggested PQQ itself can inhibit LDH activity by
directly binding to the enzyme, specifically LDHA of the skeletal muscle, and catalyzing
the oxidation of NADH to NAD+ to promote the formation of pyruvate instead
(Akagawa et al., 2016). Akagawa et al. (2016) suggest PQQ does not impact LDHA
protein abundance, which this current study’s data supports. However, activity studies
would be needed to further confirm Akagawa et al.’s (2016) findings. Increased pyruvate
production facilitated by PQQ-bound LDH implies increased energy production, though
no functional test was conducted during this study to confirm.

4.1.2

CAT Activity

Though extracellular LDH activity proved to be an ineffective method to measure OS, the
relative abundance and activity of relevant endogenous antioxidants is can also be used as
proxy measurement, as decreased activity abundance and activity infers increased ROS
accumulation (Ighodaro & Akinloye, 2018). Catalase (CAT) is among the most important
antioxidant mechanisms when it comes to decreasing H2O2 directly, as its activity is
increased during cellular ROS production to decompose H2O2 into water and oxygen to
prevent damage (Ighodaro & Akinloye, 2018). Several contradicting studies have been
published regarding the activity of CAT during incidences of OS specifically, including
in skeletal muscle directly. Many of muscle-focused studies examined the activity of
CAT in response to exercise or aging, both known promoters of ROS production and OS,
and CAT has been shown to be both increased and decreased, as well as not effected
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under such conditions (Berzosa et al., 2011; Ji, Dillon, & Wu, 1990; Lauer et al., 2005;
Sullivan-Gunn & Lewandowski, 2013). Of note however, a recent postnatal IUGR pig
model showed growth restriction to be associated with a significant decrease in CAT
activity within the skeletal muscle, alongside decreased mRNA expression (L. Zhang et
al., 2020). Overall, it has been concluded that OS is associated with decreased CAT
activity, contributing to the pathological concentrations of OS (Ahmed Amar, Eryilmaz,
Demir, Aykan, & Demir, 2019), while exercise is more commonly associated with
increased CAT activity, as ROS remains at physiological concentrations (Dao et al.,
2011).
It was hypothesized that a decrease in CAT activity would be evident after acute H2O2
exposure in the developing myotubes in line with the past OS research; it appears
relatively high levels of H2O2 can outcompete cellular mechanisms that promote CAT
production, and subsequently prevent the antioxidant’s induction in in vitro settings
(Martins & English, 2014). . Conversely, lower doses of H2O2 have been shown to induce
CAT activity and protect against oxidative damage (Martins & English, 2014). In the
current setting, there was no change in CAT activity observed in this study. In support of
this finding though, one hour exposure of 1mM of H2O2 to in vitro yeast cells, in which
CAT is highly abundant, surprisingly resulted in weak CAT activity stimulation and a
significant decrease in cell viability (Martins & English, 2014). In short, this could be
why an increase in CAT activity was not observed in this study, but further supports the
study’s assumption that 1mM H2O2 could model OS within the developing myotubes.
In addition to studies showing supplementation of other antioxidant-like compounds has
the same positive effect in several organs, including postnatal IUGR skeletal muscle
(Santos, Freitas, Xavier, Saldanha, & Freitas, 2008; L. Zhang et al., 2020), two recent
studies have shown PQQ alone to increase in vitro neuronal and in vivo adult renal CAT
activity in the presence of OS (Guan et al., 2015; Kumar & Kar, 2014). Interestingly, the
present study did not observe the same increase. It is important to note that the increases
in CAT activity observed in the Guan et al. (2015) and Kumar and Kar (2014) studies
were only significantly increased compared to samples with decreased CAT activity as a
result of cellular damage associated with OS, not compared to control samples. As this
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study did not observe elevated LDH release from cells after H2O2 exposure, it can be
concluded severe OS and associated damage was not present, unlike the previous studies
in which a change in CAT was observed after PQQ exposure. Therefore, it is not
surprising a significant increase in CAT activity after PQQ supplementation did not
occur.

4.1.3

SOD Activity and Total Protein Abundance

There is an observed correlation between increased total SOD activity and elevated H2O2
concentrations, as the enzyme aids in the dismutation of superoxide into H2O2, which is
observed under physiological conditions to prevent cellular damage (Younus, 2018).
Conversely, exogenous H2O2 exposure directly has been shown to inhibit SOD3 (I.e.,
extracellular SOD) activity specifically (Casano ’, Gomez, Lascano, Gonzalez, & Trippi,
1997; Wedgwood et al., 2011), through peroxidase activity (Jewett, Rocklin, Ghanevati,
Abel, & Marach, 1999; Wedgwood et al., 2011). IUGR is also associated with a
significant decrease in total SOD activity (H. Zhang, Li, & Wang, 2015). In contrast to
these observations, 12H 500uM/L H2O2 exposure to developing C2C12 myoblasts
resulted in decrease of total SOD activity that was nonsignificant (Li et al., 2020).
Similarly, the response the cells had to H2O2 exposure in this study regarding total SOD
activity, was decreased but not significantly in comparison to control. Therefore, the
current study supports the findings of Li et al. (2020).
Not unlike CAT, PQQ, has been shown to increase SOD activity during insult (Kumar &
Kar, 2014). Interestingly, however other studies have shown the opposite, in which the
enzyme’s activity is decreased due to PQQ supplementation after a maternal high-fat diet
insult (Jonscher, Stewart, Alfonso-Garcia, DeFelice, Wang, Luo, Levi, Heerwagen,
Janssen, De La Houssaye, et al., 2017). Of note, the study in which PQQ upregulated
SOD activity were conducted in adult mice (Guan et al., 2015), while PQQ exposure in
utero resulted in the significant decrease to SOD1 activity within developing fetal mouse
liver in the Jonscher et al. (2017) study after insult. It is important to note the same study
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showed that relative to control, SOD activity was unaltered by PQQ exposure alone. In
alignment with the Jonscher et al. (2017) study, in the current study, PQQ exposure alone
did not increase total SOD activity within the developing myotubes compared to control,
nor was total protein abundance of SOD2 affected. Conversely, the same significant
decrease observed in SOD activity after insult in the Jonscher et al. (2017) study was not
observed, in samples exposed to PQQ and H2O2 in combination. Though, as stated
regarding CAT activity above too, LDH activity in culture media in this study was not
elevated after H2O2 exposure, and therefore it can be concluded severe OS and
associated damage was not present. Thus, a significant insult was likely not present in
this study’s in vitro model, unlike the insult present in Jonscher et al. (2017) experiments,
so PQQ was unlikely then to decrease SOD experience when paired with the H2O2
exposure.

4.1.4

H2O2 and Sodium Pyruvate

It is important to note the activity assays conducted during this study were completed
with cells cultured with media supplemented with sodium pyruvate. The addition of
sodium pyruvate to cell culture media has been shown to promote cell survival, hence
why it was initially added to the study’s culture system as per many established culture
protocols (Alvarez-Elizondo, Barenholz-Cohen, & Weihs, 2019; Bergemann, Rebl, Otto,
Matschke, & Nebe, 2019). Unfortunately, it has also been shown to suppress pathways in
which PQQ is known to act on, including PGC-1𝛼 and its downstream mitochondrial
targets within the same cell type (Philp, Perez-Schindler, Green, Hamilton, & Baar,
2010). More importantly, it has been shown itself to quench H2O2 within cell culture
media, thereby inhibiting the ability of H2O2 to induce OS within the cells (Kelts, Cali,
Duellman, & Shultz, 2015). It is therefore likely that the addition of sodium pyruvate to
the cell culture media before the conduction of the studies’ activity assays likely affected
the results, in that OS was likely not fully induced in the cells, compared to other studies
utilizing H2O2 to induce oxidative damage.
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4.2 Expression of myogenesis regulators is negatively
impacted by H2O2, IUGR, and PQQ
The mechanisms by which IUGR specifically effects myogenesis are well-defined
(Chang et al., 2020), except for the specific role OS plays in said pathology, which
remains unclear. Similarly, the effects of PQQ on fetal skeletal muscle development are
relatively unknown, as its effects on the organ have been primarily studied in adult
muscle samples (Kuo, Shih, Kao, Yeh, & Lee, 2015; Ma et al., 2019), or have focused on
mitochondrial function in fetal skeletal muscle (Pendleton et al., 2020). Studies
conducted using in vitro models of myotubes have additionally not measured markers of
myogenesis directly, and instead have focused on the compound’s antioxidant and
metabolic effects (Supruniuk, Miklosz, & Chabowski, 2020; Xu et al., 2018). Hence, this
study aimed to fill these gaps in research.
First, it was observed that acute in vitro H2O2 exposure significant decreased the
expression of Myod and its downstream target, Myog. As stated previously, both these
genes promote muscle differentiation, and the decreased expression seen as a result of
H2O2 would infer decreased development of myotubes. Furthermore, IUGR was also
associated with decreased expression of both genes (Chang et al., 2020). Studies have
shown an association between IUGR and OS (Rashid et al., 2018), and so it could be
inferred by these results that the OS the occurs during IUGR is at least partly responsible
for the decreased myogenesis and subsequent diminished skeletal muscle mass. The fact
that in this study’s culture system, OS negatively impacted myogenesis markers, is strong
evidence that this system may be in operation in developing fetal skeletal muscle as well.
Additionally, this conclusion is supported by previous research aimed at understanding
the mechanism underlying the actions of OS on myogenesis, in which OS has been
shown to increase Nf-𝜅B acitivity, which in turn inhibits myogenesis and decreases
expression of Myod (Kozakowska, Pietraszek-Gremplewicz, Jozkowicz, & Dulak, 2015).
In another model of IUGR, fetal gene expression of Pax7 did not change within
semitendinosus muscle, but IUGR was still associated with impaired proliferation of
Pax7+ myoblasts (Dustin T Yates et al., 2014), demonstrated by reduced incorporation of
5-Bromo-2’-deoxyuridine (BrdU) in cells isolated from IUGR fetuses (Dustin T Yates et
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al., 2014). In support of this study, Pax7 expression was not affected by H2O2, though
expression was decreased in association with IUGR.
It was initially hypothesized that PQQ would reduce OS, and subsequently, protect
myogenic regulator factors from the downregulation seen in IUGR (Dustin T Yates et al.,
2014). Surprisingly, low and high dose PQQ exposure throughout the 7 days of myotube
differentiation in vitro resulted in a significant decrease in Myod1, and the compound did
significantly decreased expression of Pax7 at all time-points explored. Similarly, the in
vivo PQQ and IUGR/PQQ muscle tissue, had decreased Pax7, Myod1, and Myog mRNA
expression. The negative effects of PQQ alone on Myod1 were only evident specifically
after long-term PQQ exposure in vivo and in vitro during early development, hence the
inferred long-term reduction in ROS production by PQQ in early development appeared
to be detrimental to myogenesis progression. As referenced earlier, this phenomenon has
been seen in placental development, in that early supplementation of mitochondrial
antioxidant, MitoQ, inhibited growth of the organ (Yang et al., 2021).
Though proliferation is supported by a relative decrease in ROS production,
physiological concentrations of ROS are important for skeletal muscle differentiation,
and there is a documented decrease in expression of endogenous antioxidant enzymes in
line with increases in Myod and Myog expression (Kozakowska et al., 2015). In
developing C2C12 myoblasts specifically, an artificial increase in antioxidant
mechanisms was shown inhibit Pax7 and Myod expression, shown to be the result of
reductive stress (RS) (Rajasekaran, Shelar, Jones, & Hoidal, 2020). RS can be considered
the opposite of OS, though still pathological, in which cells become more reduced
relative to a normal state. This overexpression reduces physiological ROS levels, in turn
inhibiting ROS cell signaling that would otherwise promote muscle development (PérezTorres, Guarner-Lans, & Rubio-Ruiz, 2017), which is further supported by the decreased
of Pax7 and Myod1 observed by Rajasekaran et al. (2020). It could therefore be inferred
that PQQ exposure induced RS within the developing in vitro myotubes and in vivo
muscle, resulted in inhibited myogenesis, represented by the observed decrease in
expression of Pax7, Myod1, and Myog in both models.

71

4.3 IUGR and PQQ Independently Altered Gastrocnemius
Fiber Type
The observed changes in expression of myosin heavy chain isoforms indicates that IUGR
and maternal PQQ consumption both influenced fetal skeletal muscle fiber type. The
gastrocnemius of the fetal and adult guinea pig is composed of both slow oxidative type I
and fast oxidative or glycolytic type II fibers (Aquin, Sillau, Lechner, & Banchero, 1980).
Myh7 is expressed in type I fibers (Stuart et al., 2016), while fast oxidative fibers, types
IIa and IIx, express Myh2 and Myh1 respectively (Tonge, Jones, Bardsley, & Parr, 2010).
Type 2b fast glycolytic fibers express Myh4 (Tonge et al., 2010), though this fiber type is
absent in humans (Harridge, 2007). IUGR was associated with a higher proportion of
type I oxidative fibers, seen in early life piglets, in which there was a significant increase
in type I fibers compared to type II (Bauer et al., 2006). In partial support of this study,
the observed decrease in Myh4 and Myh1 in control diet IUGR animals suggests the
adverse IUGR environment alone promotes processed associated with oxidative
metabolism and increased type I fiber numbers, though Myh7 expression was also
decreased, and IUGR alone did not affect Myh2 expression. It is important to note that
the results of this study are limited in that the concentration of each fiber type was not
directly measured, as done by Bauer et al. (2006), and further research examining the
developmental consequences of the observed mRNA expression changes on fiber type
composition need to be conducted.
This decreased expression of myosin heavy chain isoforms associated with type II fibers,
seen in association with IUGR, could also be the result of increased oxidative damage to
the more susceptible fiber type. Increased ROS production is associated with IUGR
(Rashid et al., 2018), but the impact of ROS on muscle fiber composition in IUGR are illdefined. Though, exercise does result in an increased production of ROS too within the
skeletal muscle and the body appears to favor the switch to type I fibers due to their
better ROS scavenging abilities (Powers, Ji, Kavazis, & Jackson, 2011; Schantz & Dhoot,
1987). Compared to type I fibers , type II fibers are more prone to oxidative damage
(Schantz & Dhoot, 1987), which has also been specifically observed within the chosen
muscle type of this study, the gastrocnemius muscle (Koutakis et al., 2014).
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Similarly, maternal PQQ consumption alone specifically decreased Myh4, again
suggesting a shift towards more oxidative metabolism. This result along with the
decreased Myf4 expression observed due to IUGR, highlight a potential adverse effect of
maternal PQQ supplementation and IUGR on early muscle development. Studies have
shown that in regard to later life metabolic insults, sufficient type II fibers are important
for adequate energy production using fatty acid oxidation (Izumiya et al., 2008). In short,
the reduction in Myh4 observed in this study could indicate IUGR and surprisingly PQQ
predisposes individuals to diminishing capacity to combat metabolic disease. In addition,
decreased Myod1 expression is associated with inhibited type II fiber development, as
Myod1 expression is relatively higher in type II fibers, compared to type I (Talbot &
Maves, 2016). The results of this study further support this finding, as both Myod1 and
Myf4 gene expression were both decreased in IUGR and PQQ exposed fetal muscle.
Again, the current study was conducted at the mRNA expression level, and further
studies are needed to confirm if the reduction in Myh4 expression translates to
diminished type II fiber growth.
Similar to the prediction that increased ROS resulted in diminished expression of type II
fiber myosin heavy chain isoforms in IUGR, early PQQ exposure itself could be
promoting oxidative damage within developing skeletal muscle. The potential
cytotoxicity of PQQ within the organ should therefore be studied more thoroughly. In
vivo fibroblast growth studies in the context of cancer progression have shown that PQQ
promotes apoptosis and increases intracellular ROS concentrations under conditions of
high concentration PQQ exposure (Min et al., 2014). Our maternal PQQ dose was
equivalent to supplement doses available on the market (I.e., 10-20 mg), though
compared to the average daily consumption of PQQ through food human’s intake, 0.1-1.0
mg per day (Harris et al., 2013), it was relatively high and was administered for an
extended period of time during fetal development. In comparison, previous human
studies that saw a positive effect only administered equivalent doses of PQQ for 48-76
hours (Harris et al., 2013). These factors combined could have resulted in the same
negative effects accumulating over time within the fetal muscle before sample collection,
as seen with the previously mentioned repeated fetal exposure to similar compound,
MitoQ, in which development of the pancreas was inhibited (Roberts et al., 2014).
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When IUGR occurred in conjunction with maternal PQQ intake, fiber type changes as
identified above as occurring in IUGR or PQQ alone cohorts appeared to be more
apparent, in that IUGR/PQQ animals displayed significantly decreased expression of all
studied MHCs, though the mechanisms behind this finding are unknown. These results
suggest inhibited development of all fiber types, though the physiological implications of
this are not well defined. As this data is too at the mRNA level, further examination is
needed for a more sufficient idea of IUGR and PQQ’s combined effects on fiber type
proportions and function.
Lastly, the Pgc-1𝛼-Nrf-Tfam pathway, is considered the main regulatory pathway
associated with fiber type adaptions to ROS associated with exercise (Wright et al.,
2007), as the scavenging ability of skeletal muscle is partly dictated by its relative
function and mitochondrial number (A. Cheng et al., 2016). Increased expression of Pgc1𝛼 and Tfam is often associated as with increased mitochondrial biogenesis and
concentration respectively, specifically in regard to skeletal muscle mitochondria (Baar et
al., 2002; Gordon, Rungi, Inagaki, & Hood, 2001), and expression of both is increased as
a result of exercise to combat potential oxidative stress (Jung & Kim, 2014; Theilen,
Kunkel, & Tyagi, 2017). In regard to fiber type specifically, increased expression of
PGC-1𝛼 is associated with a higher proportion of oxidative muscle fiber types in adult
mice (Lin et al., 2002), which as stated previously help protect the organ from oxidative
damage. Interestingly, in this current study, IUGR and PQQ exposed gastrocnemius
muscle had decreased relative Pgc-1a mRNA expression, as well as Tfam expression that
was decreased. This would primarily suggest a decrease in type I fiber production, but as
mentioned, no decrease in Myh7 was observed. Compellingly, more recent studies found
Pgc-1𝛼 to be dispensable in fiber type switching, in that knockout of the mitochondrial
gene did not or only moderately decreased the number of type I fibers present (Handschin
et al., 2007; Zechner et al., 2010). Overall, though the decreases in Pgc-1𝛼 and
downstream Tfam may mean decreases in muscle mitochondrial function, the role these
changes play in muscle fiber determination appear to be limited in the current study and
others.
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4.4 The impact of H2O2, IUGR, and PQQ on Markers of
Mitochondrial Metabolism
As previously stated, IUGR is associated with muscle mitochondrial dysfunction (Rashid
et al., 2018), though the specific genes affected during said dysfunction is not clear. For
one, contradicting studies have been published in regard to Pgc-1𝛼 mRNA expression in
relation to IUGR, with some showing an increase while others have documented a
significant decrease dependent on the organ studied (Jones et al., 2019; Liu et al., 2012).
Of interest, however is the significant decrease in Pgc-1𝛼 gene expression evident in
adult skeletal muscle after IUGR specifically (Liu et al., 2012; Zeng et al., 2013), as the
current study also identified the same decreased in fetal IUGR muscle. PQQ has been
shown to significantly increase Pgc-1𝛼 expression directly to promote mitochondrial
biogenesis with the liver (Chowanadisai et al., 2009), and therefore was proposed to be a
plausible treatment for IUGR-associated mitochondrial dysfunction in this muscle study.
PQQ did not have the same effect in both in vitro myotubes, in which expression was
unaffected, and in vivo skeletal muscle, as PQQ significantly decreased expression of
Pgc-1𝛼 alone. Similarly, total protein abundance of PGC-1𝛼 was unaffected in
developing myotubes exposed to PQQ. It is important to acknowledge that myotubes
were only allowed to differentiate for 7 days in culture, and hence the in vitro experiment
could be considered “short-term” in comparison to the in vivo studies in which fetal
muscle was exposed to PQQ for weeks. This could explain discrepancies between Pgc1𝛼’s lack of change in total protein abundance, in comparison to the significant decrease
observed in fetal tissue. PGC-1𝛼 protein has a longer half-life then other mitochondrial
proteins (Wright et al., 2007), and therefore the expression decrease seen in IUGR fetal
tissue may have been evident in the cells if culture experiments were able to be carried
out for an extended period of time.
Several up and downstream genes of Pgc-1𝛼 were also studied. Sirt1 and Sirt3 both
increasing expression of the gene, in addition to Pgc-1𝛼 also increasing Sirt3 expression
in a positive feedback loop style, and therefore are both Sirt1 and 3 are critical
components cellular metabolism (H. Yamamoto, Schoonjans, & Auwerx, 2007). A
previous study had shown PQQ to increase the expression of both Sirt1 and 3 in in vitro
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liver (Jian Zhang et al., 2015), though like the previously mentioned effects on Pgc-1𝛼,
PQQ supplementation in fetal skeletal muscle resulted in significantly decreased
expression of Sirt3 and Sirt1 expression was decreased though not significantly. PQQ
supplementation also did not affect total protein abundance of SIRT3 in the in vitro
myotubes, which was surprising due to SIRT3’s relatively short-half (Iwahara, Bonasio,
Narendra, & Reinberg, 2012). It is evident that PQQ likely has organ-specific effects on
mitochondrial gene expression, and likely subsequent function, though protein studies do
not correlate with mRNA effects and activity assay was not conducted to test for
functional changes. The same significant decreases were seen in fetal IUGR samples,
those this was in support of recent research in which SIRT3 protein expression was
downregulated in placental samples (Naha et al., 2020), and research showing Sirt1
mRNA expression to be significantly decreased in the brains of IUGR offspring (Caprau
et al., 2007). Tfam, a regulator of mitochondrial DNA transcription, is also downstream
of Pgc-1𝛼, and is associated with decreased expression during IUGR, specifically evident
in skeletal muscle (Liu et al., 2012); the results of the current study support this finding.
It is important to note that though early research implied that decreased Tfam expression
coincided with decreased mitochondrial biogenesis and subsequent organelle
dysfunction, this is not always the case. Functional tests should be conducted to
determine the significance of changes in Tfam expression specifically within the IUGR
model to confirm mitochondrial dysfunction (Kozhukhar & Alexeyev, 2019). PQQ has
been shown to have the opposite effect, in that short-term exposure induced Tfam
expression in developing liver cells (Chowanadisai et al., 2010). In this study, PQQ alone
did not affect Tfam expression in fetal skeletal muscle, though this is supported by
another study in which continuous administration of PQQ to hindlimb skeletal muscle did
not increase TFAM protein expression significantly (Kuo et al., 2015).
Another mitochondrial gene known to be negatively affected in IUGR is that of the
enzyme carnitine palmitoyltransferase-1 (CPT-1), which is associated with fatty acid
oxidation within skeletal muscle (Sebastián et al., 2009); mRNA expression of Cpt-1 has
been shown to be significantly reduced in postnatal brains of IUGR rat offspring
(Puglianiello, Germani, Antignani, Tomba, & Cianfarani, 2007). In support of this earlier
study, Cpt-1𝛽 (I.e., the skeletal muscle isoform of Cpt-1) was documented in this study to
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be significantly decreased as a result of IUGR. The effects of PQQ alone on Cpt-1𝛽 are
unknown, and therefore this study presents a novel finding that the compound
significantly decreases expression. It is however known the Pgc-1𝛼 regulates the
functionality of Cpt-1𝛽 within the skeletal muscle (Lane et al., 2003), and therefore, the
observed decreased in Pgc-1𝛼 mRNA expression could be the cause. Again, the
functional effects of this decrease, along with the other identified, were not studied.
Therefore, the consequences of the relative decreases in mRNA are unknown at this time,
though it is inferred that these findings imply mitochondrial dysfunction.
Lastly, relative uncoupling protein 2 (Ucp2) expression was measured as a marker of
mitochondrial function, as the protein serves to regulate oxidative phosphorylation (Tian,
Ma, Tse, Wong, & Huang, 2018). Importantly, Ucp2 also serves to attenuate ROS
production and protect the mitochondria from oxidative damage (Brand & Esteves,
2005). Though Ucp2 mRNA expression has been shown to be decreased in fetal IUGR
sheep islets (Kelly et al., 2017), it has also been shown to be increased in the postnatal
IUGR skeletal muscle (Lane et al., 2003) and unaffected in postnatal IUGR piglet liver
(Ferenc et al., 2018). This study observed a significant decrease in Ucp2 in IUGR and
even more so IUGR/PQQ in the fetal skeletal muscle. It is evident that Ucp2 mRNA
expression during IUGR is largely dependent on the organ studied and the relative stage
of development in which sample collection occurs; gene expression in utero and postnatal
within the same organ appears to able to vary greatly, prompting the need for longitudinal
studies. Even so, the decrease in Ucp2 gene expression in this current study implies
increased OS stress within the two sample groups. It is also important to note that
postnatal OS has been shown to induce Pgc-1𝛼 expression for downstream induction of
endogenous antioxidant mechanisms, including Ucp2, in the response to ischemic brains
to prevent damage (S. Der Chen et al., 2011), but this protective mechanism appears to be
lost in this study’s IUGR and PQQ exposed muscle, denoted by the decreased Pgc-1𝛼
and Ucp2 observed.
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4.5 Negative Impact of IUGR and PQQ on PPAR
expression
PPAR expression in muscle, including during in utero muscle growth, has not been well
studied. The majority of studies have focused on the importance of PPARs within the
liver and adipose tissue, due to their relatively high expression within these organs
(Kersten, Desvergne, & Wahli, 2000). Past research highlighted a plausible relationship
between decreased PPAR-𝛾 and enhanced growth restriction under hypoxic conditions
(Julian et al., 2014), as IUGR development is associated with a hypoxic growth
environment as previously described (Ream, Ray, Chandra, & Chikaraishi, 2008). In
support of this, a significant decrease of relative mRNA expression of PPAR-𝛼, 𝛿, and 𝛾
in all IUGR animals was found in this study.
Independent of IUGR, PQQ administration alone was also associated with significant
decreases in muscle PPAR- 𝛼, and 𝛿 mRNA in normal growth animals. Within the
postnatal liver, prolonged PQQ exposure has little effect on relative PPAR-𝛼 mRNA
expression (Bauerly et al., 2011). In comparison, there was a significant decrease
observed in this study. Of note, a decrease in PPAR- 𝛾 mRNA in the same animals was
trending towards significance. These results suggest both fetal growth restriction and
exposure to PQQ during development negatively affect key regulators of energy
homeostasis within the skeletal muscle. It is important to highlight that Bauerly and
colleagues (2011) study was conducted with adult rats, versus the fetal tissue employed in
this study; fetal and adult tissue have been shown to have varying expression of each of
the PPARs (Abbott, Wood, Watkins, Das, & Lau, 2010). Though, it is now evident that
PQQ likely has organ-specific effects on PPAR expression. These studies together
highlight possible variabilities in gene expression regulation during versus after the
critical in utero developmental window that are important to consider when interpreting
results. In more detail, PPAR expression in utero appears to be more susceptible to
epigenetic alteration. The expression of each is easily affected by many early life insults
including adaptions to changes in maternal diet in an attempt to adapt to the insult and
promote organ function postnatally. In utero epigenetic changes to PPAR-𝛼 specifically
have been shown to occur and be stable long-term (Lillycrop, Phillips, Jackson, Hanson,
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& Burdge, 2005). These stable adaptions of PPARs as a result of in utero exposures
could predispose the developing fetus to metabolic irregularities later in life, when
ultimately, their diet and environment is likely more sufficient (Lian, Deng, Chen, &
Deng, 2018; Rees, McNeil, & Maloney, 2008). Therefore, IUGR and PQQ’s independent
effects on PPAR expression warrant further, long-term investigation.
Modifications to PPAR expression in turn can lead to changes to the mitochondria.
Reduction in PPAR-𝛽/𝛿 expression in the skeletal muscle of adult mice results in
decreased mitochondrial oxidative capacity, and related fiber type switching to increased
type II fiber concentrations (Schuler et al., 2006). Interestingly, the data of this study does
not support the Schuler et al. (2006), as both a decrease in all PPARs and Myf4 was
observed. Conversely, activation of PPAR-𝛾 promoted mitochondrial biogenesis in part
to due to downstream upregulation of Pgc-1a and Tfam, though this effect was not
studied in skeletal muscle (Miglio et al., 2009). It could then be inferred from presented
data that the IUGR and PQQ fetal animals independently will have associated
mitochondrial dysfunction due to changes in PPAR expression, as result of the presented
decreased expression of each PPAR, in addition to the decreases observed in Pgc-1𝛼, and
Tfam expression described. This appears to be the first study of this nature.

4.6 The ETC of skeletal muscle is negatively affected by
H2O2, IUGR, and PQQ
Hypermethylation of ETC complex I subunit Ndufb6 and complex IV subunit Cox7a1
has been observed in the muscle of those with T2DM phenotypes (Zhou, Sun, Li, & Zhu,
2018), and since IUGR is associated with increased incident of said metabolic disorder, it
is therefore likely changes to these genes contributed to the mitochondrial dysfunction
evident in these offspring too (Mandò et al., 2014; Pendleton et al., 2020). Though the
mechanisms of said hypermethylation are not well known, oxidative stress induced
epigenetic regulation has been proposed (Strakovsky & Pan, 2012). In support of these
hypotheses, it was observed in this study that acute hydrogen peroxide exposure to
developing myotubes resulted in significantly decreased Ndufb6 and Cox7a1 mRNA
expression. Similarly, relative expression of both markers was significantly decreased in
the gastrocnemius of fetal IUGR animals. However, it cannot be confirmed that oxidative
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stress was present and responsible, as no markers of said stress were examined in the
guinea pig model. Though, Complex I and Complex IV dysregulation is associated with
wide-scale mitochondrial dysfunction resulting in increased oxidative stress and it can
therefore be inferred that oxidative stress is present within our IUGR model due to
diminished Ndufb6 and Cox7a1 expression. Relative mRNA expression of Atp5a1 and
Atp5pb, both subunits of complex V, was also significantly decreased in IUGR animals,
suggesting further impairment to oxidative phosphorylation and long-term mitochondrial
defects, including further oxidative damage (Jonckheere et al., 2013; Lebiedzinska et al.,
2013).
Oxygen consumption is significantly decreased in the skeletal muscle, associated with
reduced complex I activity in IUGR fetal sheep skeletal muscle, which is postulated to
lower potential oxidative damage to the organ (Pendleton et al., 2020). The data from the
described study supports this finding, as the decrease in Ndufb6 in fetal IUGR animals
could be associated with decreased complex I activity. It is important to note that another
study found complex I activity to be unaffected in skeletal muscle of older IUGR
neonatal piglets with no change in expression of complex I subunits (K. Cheng et al.,
2020), highlighting a need for further research of the stability of changes in fetal gene
expression. Similarly, preliminary unpublished data in continuation of the present study
found Ndufb6 expression to be unchanged in IUGR guinea pig offspring at 4 months of
age, supporting the Cheng et al. (2020) study. It could be inferred the decrease in
complex I seen in fetal skeletal muscle is a compensatory change that is no longer needed
to prevent oxidative damage in a relative normoxic postnatal environment and hence is
reversed. Comparatively, there were no observed protein abundance changes of the
complexes within this study as a result of acute hydrogen peroxide exposure, though this
is supported by other literature which suggests posttranscriptional regulatory events are
present in IUGR that result in discrepancies between mRNA expression and protein
concentration, specifically in regard to the complexes (Mandò et al., 2014; Pendleton et
al., 2020).
Lastly, limited data has been published that suggests PQQ can induce complex I activity
in livers in vitro (T. Stites et al., 2006). Likewise, low dose RSV has also been shown to
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directly bind to complex I and increase its activity within the brain (Gueguen et al.,
2015). As a result of these described studies, it was predicted PQQ would increase
mitochondrial function by affecting complex I as well. The opposite was observed in this
study’s cell culture model, as PQQ resulted in significantly decreased Ndufb6 expression,
though functional tests were not conducted to confirm changes in activity. The same gene
was unaffected by maternal PQQ intake in the in vivo model. Comparatively, long-term
PQQ exposure decreased Cox7a1 expression in developing myotubes, while expression
was unchanged in maternal PQQ exposed fetal animals. In comparison to other studies,
developing liver exposed to PQQ has been shown to exhibit increased Complex IV
activity (Chowanadisai et al., 2010). Lastly, PQQ did not affect protein abundance of the
complexes in vitro. In short, the effects of PQQ on the ETC complexes in skeletal muscle
are still unclear. It is important to note that all described studies focused on the effects off
PQQ and RSV in in vitro and postnatal liver and brain, while this study examined PQQ’s
effects in fetal skeletal muscle development. The organ differences between studies could
possibly explaining the discrepancies seen.

4.7 Limitations
Firstly, the cell culture model utilized has several limitations to acknowledge. As
previously referenced, the C2C12 cell line is commonly utilized to mimic in utero
skeletal muscle growth (Jing Zhang et al., 2019), but it is important to recognize that it is
transformed adult mouse cells and hence may have altered processes related to
myogenesis and mitochondrial function (Abdelmoez et al., 2020). Secondly, the
utilization of H2O2 to mimic oxidative stress within the cells did not allow for
longitudinal studies, as H2O2 is quite detrimental to C2C12 survival after 24H exposure
and is not commonly utilized past this time point (Gülden, Jess, Kammann, Maser, &
Seibert, 2010; Siu, Wang, & Alway, 2009). Since oxidative stress present in IUGR occurs
for an extended period of time (Potdar et al., 2009), the acute H2O2 exposure utilized is
hence limited in how effectively it can be compared to any adverse pregnancy condition.
Media with a high glucose concentration (25mM) is also utilized to proliferate and
differentiate the cells and it could therefore be said that the cells were not grown in a
physiologically relevant environment. Similarly, cells were grown in 21% O2, whereas
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fetal development occurs in relative hypoxia at 5% O2. Lastly, the sex of the C2C12 cells
is female, while in vivo studies were conducted in male tissue, and therefore comparisons
between models may be flawed, as IUGR has been shown to have sex-specific effects, in
that males are more greatly affected (Lane et al., 2003). Despite these limitations, the
study did replicate findings of other similar fetal IUGR experiments. It also appears this
is the first study of its kind utilizing C2C12 to study PQQ’s effects on skeletal muscle
development these in vitro studies allowed specific mechanistic pathways to be
examined. Regarding the guinea pig model utilized, the presented data only included
male animals; subsequent research should include female data as sex-specific changes are
prevalent in other studies of IUGR. Positively, this IUGR model is comparable to
idiopathic PI-IUGR in humans, as guinea pigs IUGR is spontaneous, and studies required
no in utero manipulation, as described in the methods.
Interpretation of the studies’ results is also limited by the prevalent use of qPCR, and
subsequent lack of protein data collected from fetal guinea pig muscle, though many
genes were examined, investigating multiple pathways of interest, which assisted in
determining future directions. As reported in this study’s cell culture experiments and
confirmed by other studies, changes in mRNA expression and protein abundance are not
always correlated. Hence, by not examining protein data in the fetal samples, the study
missed collection of relevant information to make further conclusions. In addition,
protein data presented from cell culture studies was limited in its own way, as minimal
post-translational modifications were studied, and activity assays are lacking that would
give the best overall picture of functional effects of changes in gene expression.

4.8 Future Directions
The presented data provides evidence which supports that both a H2O2 insult and an
adverse in utero environment negatively affect skeletal muscle development and key
readouts of muscle mitochondrial metabolism. Additionally, evidence is presented that
PQQ supplementation during in vitro myotube development inhibits myogenesis and key
readouts of mitochondrial function, and the same results were observed after maternal
PQQ supplementation during the key fetal muscle developmental (I.e., myogenic)
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windows. A logical progression would then be to identify if gene expression changes
found, result in relevant functional consequences. With functional in situ experiments
such as glucose uptake assays for example, the relative mitochondrial and metabolic
consequences of the changes in gene expression could be observed.
Regarding mitochondrial function specifically, H2O2, and PQQ in vitro each
independently decreased gene expression of complex I and IV subunits of the
mitochondrial ETC. Conversely, protein abundance of both complexes was unaffected,
highlighting a potential compensatory increased translational ability that may or may not
result in maintenance of ETC function. To confirm PQQ does in fact negatively affect the
ETC, activity assays for each complex should be undertaken and total mitochondrial
respiration could be measured as a representation of overall mitochondrial function after
supplementation of the compound. Similarly, protein abundance nor activity of the ETC
complexes was measured in fetal gastrocnemius muscle and should be conducted to
further substantiate relative mRNA data presented.
Furthermore, evidence is presented that OS is present in fetal IUGR development,
represented by relevant decreases in expression of key mitochondrial genes shown to be
negatively affected by the stressor in previous studies and by the relative decrease in
Ucp2 gene expression observed. Though, more direct markers of OS were not measured
within the gastrocnemius, thus should be to validate its presence. Of interest is the p53p66shc-Pin1 pathway, including the role the genes play in ROS regulation during
oxidative stress. PQQ’s effects on this pathway are also relatively unknown, and it
remains speculative if these genes play a relevant role in IUGR mitochondrial
dysfunction. On the other hand, to protect against oxidative stress three major
endogenous antioxidants exist to diminish ROS concentrations: SOD, catalase, and
glutathione (Birben et al., 2012). Relative activity of each is commonly used as a measure
of oxidative stress, with decreased activity corresponding with increased oxidative stress
(Ighodaro & Akinloye, 2018; Michiels, Raes, Toussaint, & Remacle, 1994). In vivo
muscle studies studying these antioxidants remains incomplete, and unfortunately, in
vitro activity assays showed no decrease in SOD or CAT activity after H2O2 exposure
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suggesting OS was not induced. Though, mitigating factors such as sodium pyruvate
addition to cell culture media and PQQ inhibitory effects of LDH activity should also be
considered when interpreting these in vitro results.
Lastly, several gene expression changes previously shown to be associated with
mitochondrial dysfunction during IUGR have been proposed to be the result of epigenetic
down-regulation of gene expression including increased DNA methylation as a result of
hypoxia-induced OS (Campos et al., 2007; Roifman et al., 2016). In short, it is postulated
that OS-induced DNA methylation is the mechanism responsible for the observed
mitochondrial gene expression changes in IUGR offspring and further studies should be
conducted to confirm. In support of this proposition, several genes previously associated
with mitochondrial dysfunction, including Ndufb6, Cox7a1, Cpt-1, and Pgc-1𝛼 had
decreased expression within both our model of OS, and IUGR. Overall, understanding
the epigenetic effects induced by OS would be a useful further study to understand
upstream regulators of gene expression changes that result in later life NCD in IUGR
offspring.

4.9 Conclusion
In conclusion, the initial hypothesis proved to be true, in that H2O2 and IUGR did
negatively affect markers of muscle development and mitochondrial function. Firstly,
both H2O2 and IUGR resulted in the reduction of Ndufb6 and Cox7a1 expression
(Figures 3.3.1-1,2; Figure 3.4.4-1), and the observed decreases in Pgc-1𝛼 and its
downstream counterpart’s mRNA expression in IUGR fetuses provides further context
for this finding (Figure 3.4.4-2). Though, it is of note that total protein abundance of
NDUFB8 was unaffected by acute H2O2 exposure (Figure 3.3.1-5), nor was Pgc-1𝛼 gene
or protein expression significantly (Figures 3.3.1-3,7). Even so, together these results
support the theory that in utero OS exposure as a response to a hypoxic growth
environment results in the mitochondrial dysfunction evident in IUGR. This muscle
mitochondria dysfunction is contributing factor to the increased risk of metabolic disease
in adulthood observed in IUGR offspring, including but not limited to dysfunction
associated with decreased expression of Ndufb6, Cox7a1, Pgc-1𝛼, and Cpt-1. In
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summary, the findings of this study provide evidence that OS is a likely contributor to the
observed association between IUGR and adulthood metabolic disease, including CVD
and T2DM (Zhou et al., 2018).
Secondly, in reference to myogenesis, Myod, and Myog expression were decreased as a
result of IUGR (Figure 3.4.2-1), and H2O2 (Figure 3.3.2-2,3). Not unlike the
mitochondrial function markers previously discussed, these results suggest the OS
present in utero during IUGR contributes to the reduction seen in skeletal muscle mass by
downregulating myogenesis. Furthermore, IUGR was associated with a significant
decrease in fetal muscle expression of Myf4 and Myf1 (Figure 3.4.2-2), the myosin heavy
chain isoform genes associated with type 2b and type 2x fibers, respectively. Evidently,
all type 2 fibers are the most susceptible to oxidative damage (Schantz & Dhoot, 1987)
and hence this study again suggests in utero OS plays a role changes to fiber development
seen during IUGR. Whether these changes to Myf4 and Myf1 gene expression translate
to switches in fiber type directly is unknown. Overall, these results are supported by
previous studies in which IUGR skeletal muscle growth reduction was associated with
decreased rates of myogenesis, but not increased muscle apoptosis as a result of the
hypoxic growth environment (Chang et al., 2020). Though Pax7 expression was not
affected by either H2O2 (Figure 3.3.2-1) nor IUGR (Figure 3.4.2-1), other studies have
shown that intact expression Pax7 does not necessarily infer functional proliferation and
myogenesis was still ultimately diminished in IUGR groups (D. T. Yates et al., 2012).
In contrast to the original hypothesis, PQQ did not increase expression of key markers of
mitochondrial function. For example, previous studies have shown PQQ to increase
expression of Pgc-1𝛼, but this study observed no increase within in vitro muscle cells
(Figure 3.3.1-3) while in vivo muscle had decreased expression (Figure 3.4.4-2).
Similarly, markers downstream of Pgc-1𝛼, including Sirt3 and Cpt-1𝛽, showed decreased
expression in PQQ-exposed fetal muscle (Figure 3.4.4-2) Lastly, Ndufb6 and Cox7a1
expression was also decreased by PQQ exposure in cell culture (Figure 3.3.1-1,2), though
fetal muscle samples did not show the same negative effect. Simply put, these results do
suggest that though PQQ has been shown to be beneficial to mitochondrial function in
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postnatal liver and brain, its effect in utero skeletal muscle differ and the long-term
effects of PQQ administration during gestation on mitochondrial function should be
explored. It is important to consider that PQQ administration did not affect total protein
abundance of any mitochondrial marker in culture, suggesting the observed decreases in
gene expression may take time to manifest in protein abundance or may not translate to
changes in protein abundance at all. Thus, the relative functional effects of documented
changes in mitochondrial gene expression as a result of PQQ should be examined.
Secondly, PQQ did not protect against damage to myogenesis regulation and instead
appeared to negatively affect genes involved in the process, in opposition to the original
hypothesis again. PQQ alone decreased expression of both in vitro and in vivo muscle
Myod and Myog expression (Figures 3.2.2-2,3; Figure 3.4.2-1). Furthermore, PQQ alone
significant decreased Pax7 expression in fetal muscle, unlike IUGR (Figure 3.4.2-1).
Overall, these results provide evidence that in utero PQQ exposure may dysregulate
myogenesis, and this could be the result of its antioxidant properties. It is known that
physiological levels of ROS promote differentiation of skeletal muscle, and similar
placental research showed in utero exposure to antioxidants in can inhibit said signalling
and inhibit development.
Finally, PQQ had varying effects on the expression of genes associated with skeletal
muscle fiber type. Similar to IUGR, PQQ exposure alone was associated with decreased
expression of Myf4 (Figure 3.4.2-2), though the functional significance and mechanisms
behind this decrease are relatively unknown. Additionally, the combination of IUGR and
PQQ exposure in fetal muscle appeared to augment the negative effects of IUGR on
myogenesis, in that the reductions seen in Pax7, Myod, and Myog were all greater in
IUGR/PQQ fetal tissue than the decreases seen as a result of PQQ and/or IUGR alone
(Figure 3.4.2-1). IUGR/PQQ fetal samples also had decreased expression of all fiber type
genes examined (Figure 3.4.2-2). The mechanisms behind these elevated negative
changes and the physiological relevance of these decreases in gene expression are
unknown, though the results do suggest widespread inhibition of the development all
fiber types in IUGR/PQQ fetuses and likely a greater decrease skeletal muscle mass than
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that associated with IUGR alone. The same augmentation was observed in genes
associated with mitochondrial function, including Pgc-1𝛼, Sirt1, and Tfam. Again, the
mechanisms behind this combined negative effect on gene expression have yet to be
explored, nor have their functional effects.
All together the results of this study suggest the OS during IUGR is a potential
mechanism for the muscle mitochondrial dysfunction observed in IUGR offspring. This
study additionally identified that PQQ exposure during skeletal muscle development may
be detrimental to mitochondrial function and myogenesis progression and amplify to the
adverse effects of IUGR.
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Appendix
Animal Use Protocol:
AUP Number: 2018-110
AUP Title: Modulating the in utero environment to prevent later life insulin
resistance
Yearly Renewal Date: 10/01/2021
The YEARLY RENEWAL to Animal Use Protocol (AUP) 2018-110 has been
approved by the Animal Care Committee (ACC), and will be approved through to
the above review date.
Please at this time review your AUP with your research team to ensure full understanding
by everyone listed within this AUP.
As per your declaration within this approved AUP, you are obligated to ensure that:
1) Animals used in this research project will be cared for in alignment with:
a) Western's Senate MAPPs 7.12, 7.10, and 7.15
http://www.uwo.ca/univsec/policies_procedures/research.html
b) University Council on Animal Care Policies and related Animal Care Committee
procedures
http://uwo.ca/research/services/animalethics/animal_care_and_use_policies.html
2) As per UCAC's Animal Use Protocols Policy,
a) this AUP accurately represents intended animal use;
b) external approvals associated with this AUP, including permits and
scientific/departmental peer approvals, are complete and accurate;
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c) any divergence from this AUP will not be undertaken until the related Protocol
Modification is approved by the ACC; and
d) AUP form submissions - Annual Protocol Renewals and Full AUP Renewals - will be
submitted and attended to within timeframes outlined by the ACC.
http://uwo.ca/research/services/animalethics/animal_use_protocols.html
3) As per MAPP 7.10 all individuals listed within this AUP as having any hands-on
animal contact will
a) be made familiar with and have direct access to this AUP;
b) complete all required CCAC mandatory training (training@uwo.ca); and
c) be overseen by me to ensure appropriate care and use of animals.
4) As per MAPP 7.15,
a) Practice will align with approved AUP elements;
b) Unrestricted access to all animal areas will be given to ACVS Veterinarians and ACC
Leaders;
c) UCAC policies and related ACC procedures will be followed, including but not limited
to:
i) Research Animal Procurement
ii) Animal Care and Use Records
iii) Sick Animal Response
iv) Continuing Care Visits
5) As per institutional OH&S policies, all individuals listed within this AUP who will be
using or potentially exposed to hazardous materials will have completed in advance the
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appropriate institutional OH&S training, facility-level training, and reviewed related
(M)SDS Sheets, http://www.uwo.ca/hr/learning/required/index.html
Submitted by: Copeman, Laura
on behalf of the Animal Care Committee
University Council on Animal Care
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